Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	DDX19B HSP90B1 MYH8 ERCC3 MYO1A MYO1D KIF1A MYO7A DHX38 PEX1 MCM5 ABCA8 BPTF ACSBG1 DNAH8 HSPA4L SMCHD1 DNAH7 DICER1 DDX25 KIF13A ATP5F1C	2.91e-06	614	231	22	GO:0140657
GeneOntologyMolecularFunction	chloride channel activity	GABRB1 GABRB2 CLCA1 CLCN3 CLCN4 SLC26A9 SLC1A7 ANO6	6.94e-06	86	231	8	GO:0005254
GeneOntologyMolecularFunction	monoatomic anion channel activity	GABRB1 GABRB2 CLCA1 CLCN3 CLCN4 SLC26A9 SLC1A7 ANO6	2.63e-05	103	231	8	GO:0005253
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	GABRB1 GABRB2 SLC25A3 CLCA1 CLCN3 CLCN4 SLC4A7 SLC26A9 SLC1A7 ANO6	3.14e-05	171	231	10	GO:0015103
GeneOntologyMolecularFunction	monoatomic anion transmembrane transporter activity	GABRB1 GABRB2 CLCA1 CLCN3 CLCN4 SLC4A7 SLC26A9 SLC1A7 ANO6	6.76e-05	151	231	9	GO:0008509
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH8 MYO1A MYO1D KIF1A MYO7A DNAH8 DNAH7 KIF13A	6.97e-05	118	231	8	GO:0003774
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	ARHGAP32 DOCK11 SH3BP4 RUNDC3A EIF2B4 PLCG1 TNS3 DOCK1 RASGRF2 HACD3 STXBP5 RALGAPB RAPGEF1 ARHGAP35 OPHN1 ARHGEF39 DEPDC5	9.15e-05	507	231	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	ARHGAP32 DOCK11 SH3BP4 RUNDC3A EIF2B4 PLCG1 TNS3 DOCK1 RASGRF2 HACD3 STXBP5 RALGAPB RAPGEF1 ARHGAP35 OPHN1 ARHGEF39 DEPDC5	9.15e-05	507	231	17	GO:0030695
GeneOntologyMolecularFunction	chloride transmembrane transporter activity	GABRB1 GABRB2 CLCA1 CLCN3 CLCN4 SLC26A9 SLC1A7 ANO6	1.05e-04	125	231	8	GO:0015108
GeneOntologyMolecularFunction	ATP hydrolysis activity	DDX19B HSP90B1 MYH8 ERCC3 KIF1A DHX38 PEX1 MCM5 ABCA8 DNAH8 SMCHD1 DNAH7 DDX25 KIF13A ATP5F1C	2.04e-04	441	231	15	GO:0016887
GeneOntologyMolecularFunction	voltage-gated chloride channel activity	CLCN3 CLCN4 ANO6	2.35e-04	11	231	3	GO:0005247
GeneOntologyMolecularFunction	ligand-gated monoatomic anion channel activity	GABRB1 GABRB2 CLCA1 SLC1A7 ANO6	2.75e-04	50	231	5	GO:0099095
GeneOntologyMolecularFunction	voltage-gated monoatomic anion channel activity	CLCN3 CLCN4 ANO6	9.22e-04	17	231	3	GO:0008308
GeneOntologyMolecularFunction	microfilament motor activity	MYH8 MYO1A MYO1D MYO7A	9.46e-04	38	231	4	GO:0000146
GeneOntologyBiologicalProcess	inner ear receptor cell development	GABRB2 MYO7A ALMS1 PTPRQ WHRN SLC4A7 DICER1	1.66e-05	73	229	7	GO:0060119
GeneOntologyBiologicalProcess	inorganic anion transmembrane transport	GABRB1 GABRB2 SLC25A3 CLCA1 CLCN3 CLCN4 SLC26A9 SLC1A7 ANO6	1.92e-05	134	229	9	GO:0098661
GeneOntologyBiologicalProcess	inorganic anion transport	GABRB1 GABRB2 SLC25A3 CLCA1 CLCN3 CLCN4 SLC4A7 SLC26A9 SLC1A7 ANO6	3.45e-05	180	229	10	GO:0015698
GeneOntologyBiologicalProcess	chloride transmembrane transport	GABRB1 GABRB2 CLCA1 CLCN3 CLCN4 SLC26A9 SLC1A7 ANO6	3.60e-05	112	229	8	GO:1902476
GeneOntologyBiologicalProcess	monoatomic anion transmembrane transport	GABRB1 GABRB2 CLCA1 CLCN3 CLCN4 SLC4A7 SLC26A9 SLC1A7 ANO6	5.47e-05	153	229	9	GO:0098656
GeneOntologyBiologicalProcess	cellular catabolic process	EPHB2 ENPP6 CYP1A1 CYP2C8 ZMPSTE24 SH3BP4 NEDD4 PNPLA1 SMPDL3B GABARAPL1 MVB12A UGT2B4 UGT2B10 PLCG1 PLCG2 APOB LDHA IFI16 UFM1 WASH3P VPS13D TIMP3 LZTS1 ASAH1 QPRT HGS PRKACA ATG4C DEPDC5 HAL	5.98e-05	1253	229	30	GO:0044248
GeneOntologyBiologicalProcess	protein localization to vacuole	GGA3 SH3BP4 NEDD4 MVB12A WASH3P VPS13D HGS	6.04e-05	89	229	7	GO:0072665
GeneOntologyBiologicalProcess	cell morphogenesis	EPHB2 ARHGAP32 ZMPSTE24 KIF1A MYO7A NEDD4 PRDM8 FAT1 HMCN2 PTPRD ABITRAM NFIA HPRT1 PTPRQ ACTL9 BRWD1 WHRN ANK3 STXBP5 WNT3 ARHGAP35 DICER1 OPHN1 TMEM106B LZTS1 NEXN CDH7 CDH10 EPB41	6.23e-05	1194	229	29	GO:0000902
GeneOntologyBiologicalProcess	establishment of protein localization to vacuole	GGA3 NEDD4 MVB12A WASH3P VPS13D HGS	9.14e-05	66	229	6	GO:0072666
GeneOntologyBiologicalProcess	chloride transport	GABRB1 GABRB2 CLCA1 CLCN3 CLCN4 SLC26A9 SLC1A7 ANO6	9.31e-05	128	229	8	GO:0006821
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	EPHB2 ARHGAP32 KIF1A MYO7A NEDD4 PRDM8 HMCN2 PTPRD ABITRAM HPRT1 PTPRQ ACTL9 WHRN ANK3 STXBP5 WNT3 ARHGAP35 OPHN1 TMEM106B LZTS1 NEXN	9.72e-05	748	229	21	GO:0048667
GeneOntologyBiologicalProcess	inner ear receptor cell differentiation	GABRB2 MYO7A ALMS1 PTPRQ WHRN SLC4A7 DICER1	9.78e-05	96	229	7	GO:0060113
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO2 NOMO1 NOMO3	1.08e-04	9	229	3	GO:0160063
GeneOntologyBiologicalProcess	mechanoreceptor differentiation	GABRB2 MYO7A ALMS1 PTPRQ WHRN SLC4A7 DICER1	1.62e-04	104	229	7	GO:0042490
GeneOntologyBiologicalProcess	protein targeting to vacuole	GGA3 NEDD4 WASH3P VPS13D HGS	2.07e-04	49	229	5	GO:0006623
GeneOntologyBiologicalProcess	monoatomic anion transport	GABRB1 GABRB2 CLCA1 CLCN3 CLCN4 SLC4A7 SLC26A9 SLC1A7 ANO6	2.14e-04	183	229	9	GO:0006820
GeneOntologyCellularComponent	actin-based cell projection	MYO1A MYO1D MYO7A NEDD4 FAT1 CLCA1 ABITRAM PROM2 PTPRQ WHRN SLC4A7 PKHD1L1 WASH3P	1.55e-05	278	233	13	GO:0098858
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO1 NOMO3	1.09e-04	9	233	3	GO:0160064
GeneOntologyCellularComponent	smooth endoplasmic reticulum	HSP90B1 MYO1D ERP29 APOB PDIA4	1.56e-04	46	233	5	GO:0005790
GeneOntologyCellularComponent	vesicle membrane	GABRB2 SYNRG ARHGAP32 LZTR1 ZMPSTE24 KIF1A DGKQ TLR7 DCSTAMP C2CD5 GGA3 CLCA1 GABARAPL1 CLCN3 MVB12A CLCN4 STXBP5 WNT3 ANXA6 RAPGEF1 SLC26A9 APOB SYT10 TMEM106B WASH3P SLC9A5 ANO6 HGS KIF13A AHNAK2	1.74e-04	1325	233	30	GO:0012506
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	GABRB2 SYNRG ARHGAP32 LZTR1 ZMPSTE24 KIF1A TLR7 DCSTAMP C2CD5 GGA3 CLCA1 GABARAPL1 CLCN3 MVB12A CLCN4 STXBP5 WNT3 ANXA6 RAPGEF1 SLC26A9 APOB SYT10 TMEM106B WASH3P SLC9A5 ANO6 HGS KIF13A AHNAK2	3.15e-04	1307	233	29	GO:0030659
GeneOntologyCellularComponent	endoplasmic reticulum chaperone complex	DNAJB11 HSP90B1 PDIA4	3.60e-04	13	233	3	GO:0034663
GeneOntologyCellularComponent	endosome membrane	ARHGAP32 LZTR1 ZMPSTE24 TLR7 DCSTAMP GGA3 CLCN3 MVB12A CLCN4 ANXA6 SLC26A9 APOB TMEM106B WASH3P SLC9A5 HGS KIF13A	4.45e-04	602	233	17	GO:0010008
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO2 NOMO1 NOMO3	4.54e-04	14	233	3	GO:0072379
Domain	DUF2012	NOMO2 NOMO1 NOMO3	7.31e-06	4	230	3	PF09430
Domain	DUF2012	NOMO2 NOMO1 NOMO3	7.31e-06	4	230	3	IPR019008
Domain	CarboxyPept-like_regulatory	NOMO2 CILP NOMO1 NOMO3	4.70e-05	17	230	4	IPR008969
Domain	Carb-bd-like_fold	NOMO2 NOMO1 NOMO3	9.86e-05	8	230	3	IPR013784
Domain	PLC-gamma	PLCG1 PLCG2	1.51e-04	2	230	2	IPR016279
Pathway	REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY	A2M APOB PRKACA PRKACB	4.40e-05	17	171	4	MM15561
Pathway	REACTOME_HDL_ASSEMBLY	A2M PRKACA PRKACB	5.92e-05	7	171	3	MM15560
Pathway	REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY	A2M APOB PRKACA PRKACB	7.03e-05	19	171	4	M27841
Pathway	REACTOME_HDL_ASSEMBLY	A2M PRKACA PRKACB	9.39e-05	8	171	3	M27840
Pathway	KEGG_RETINOL_METABOLISM	CYP1A1 CYP2C8 CYP2C18 UGT2B4 UGT2B10 RDH16	1.22e-04	64	171	6	M9488
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HSP90B1 CAND1 MYO1D KIF1A RPN1 BCLAF1 DHX38 GARS1 MCM5 RO60 MDH2 NEK9 EFTUD2 SLC25A3 PHF2 TXNDC5 RBM19 HPRT1 INTS11 CC2D2A ERP29 STIP1 PLCG1 NUP160 VARS1 SDHB HACD3 HSPA4L SMCHD1 ANXA6 NOC3L APOB LDHA DICER1 NOMO1 PDIA4 SBNO1 PRKACA ATP5F1C	1.33e-13	1425	237	39	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	HSP90B1 MYH8 ZMPSTE24 MYO1A MYO1D CENPC RPN1 BCLAF1 GARS1 MCM5 MDH2 NEB BPTF PRDM8 RUNDC3A CLCN3 CLCN4 CC2D2A KIAA2012 DNAH8 VARS1 GPR19 HSPA4L SMCHD1 NOC3L APOB PDIA4 SHANK2 SBNO1 PRKACA PRKACB ATG4C LSM14A PABPC1L DOP1A ATP5F1C	1.78e-11	1442	237	36	35575683
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	DDX19B DNAJB11 ARHGAP32 CAND1 DOCK11 RPN1 MCM5 TXNDC5 ANKRD28 STIP1 DOCK1 RASGRF2 HACD3 HSPA4L ANXA6 ARHGAP35 LDHA PREPL OPHN1 PDIA4 ARHGEF39 PRKACA PRKACB LSM14A EIF3G AURKB ATP5F1C	2.13e-10	916	237	27	32203420
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DNAJB11 HSP90B1 CENPC RPN1 BCLAF1 MRPL27 MDH2 C2CD5 SH3BP4 EFTUD2 TXNDC5 NOMO2 EIF2B4 SCO1 ANKRD28 ERP29 STIP1 SDHB SLC4A7 ANK3 HACD3 HSPA4L RALGAPB NOC3L ZDHHC5 PREPL DICER1 NOMO1 PDIA4 ANO6 MAP4K5 HGS PRKACA PRKACB	6.85e-10	1487	237	34	33957083
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	A2M DNAJB11 LZTR1 CAND1 KIF1A MCM5 C2CD5 WWC2 PTPRD TXNDC5 EIF2B4 SCO1 ANKRD28 STIP1 PLCG1 NUP160 VARS1 SDHB TNS3 ADRM1 HACD3 HSPA4L SMCHD1 PREPL DICER1 NOMO1 PDIA4	8.11e-10	974	237	27	28675297
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DNAJB11 ARHGAP32 HSP90B1 LZTR1 MYO1D CENPC DHX38 PHF2 PHKB WWC2 PTPRD TXNDC5 SMG7 INTS11 ANKRD28 MICAL3 STIP1 TNS3 ANK3 RALGAPB NOC3L ZDHHC5 PABIR2 PDIA4 HGS PRKACA PHLPP2 AURKB	8.93e-10	1049	237	28	27880917
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	EPHB2 MYH8 ERCC3 BCLAF1 PEX1 NEK9 C2CD5 PHKB RUNDC3A ANAPC10 GABARAPL1 AGO3 NOMO2 SYK PLCG1 TNS3 ADRM1 HSPA4L DICER1 NOMO1 MAP4K5 PRKACB EIF3G NOMO3 TUBAL3 AURKB	9.08e-10	910	237	26	36736316
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DNAJB11 HSP90B1 ERCC3 CAND1 CENPC UBE4B RPN1 DHX38 GARS1 MCM5 NEK9 EFTUD2 SLC25A3 RBM19 EIF2B4 INTS11 ANKRD28 ERP29 PLCG1 PLCG2 NUP160 VARS1 TNS3 HACD3 SMCHD1 NOC3L LDHA IFI16 MAP4K5 NEXN AHNAK2 ATP5F1C	1.01e-09	1353	237	32	29467282
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	DDX19B DNAJB11 HSP90B1 CAND1 UBE4B DHX38 GARS1 MCM5 RO60 NEK9 EFTUD2 TXNDC5 HPRT1 ANKRD28 STIP1 PLCG1 NUP160 VARS1 TNS3 ADRM1 HSPA4L ANXA6 LDHA UFM1 PDIA4 SBNO1 HGS PRKACA PRKACB N4BP1 EIF3G KIF13A AHNAK2	1.54e-09	1455	237	33	22863883
Pubmed	Mitochondrial Raf1 Regulates Glutamine Catabolism.	A2M ARHGAP32 HSP90B1 MYO1A MYO1D RPN1 ERP29 TNS3 ANK3 ZNF618 ZDHHC5 DICER1 PDIA4 LZTS1 ATP5F1C	1.61e-09	288	237	15	38496616
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ARHGAP32 CMTR1 DHX38 NEK9 ABCA8 C2CD5 EFTUD2 PHF2 ALMS1 NFIA MICAL3 NUP160 ZNF618 ZDHHC5 ARHGAP35 VPS13D N4BP1 ZNF286A DOP1A	1.62e-09	493	237	19	15368895
Pubmed	Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.	HSP90B1 CAND1 RPN1 GARS1 MCM5 EFTUD2 SLC25A3 TXNDC5 HPRT1 STIP1 VARS1 ADRM1 HSPA4L LDHA PDIA4 QPRT EIF3G EPB41 TUBAL3	1.73e-09	495	237	19	28581483
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	DNAJB11 HSP90B1 CAND1 RPN1 GARS1 MCM5 EFTUD2 SLC25A3 NOMO2 HPRT1 NUP160 VARS1 SDHB HACD3 HSPA4L LDHA TMEM106B PRKACA AURKB ATP5F1C	3.03e-09	571	237	20	37167062
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	A2M HSP90B1 UBE4B RPN1 BCLAF1 GARS1 MCM5 MDH2 EFTUD2 SLC25A3 SMPDL3B STIP1 VARS1 ADRM1 ANXA6 LDHA PDIA4 NEXN	6.11e-09	477	237	18	31300519
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CAND1 KIF1A UBE4B CMC1 NEK9 SH3BP4 PHF2 PHKB BPTF ANAPC10 SMPDL3B SMG7 NFIA PROM2 EIF2B4 SEL1L3 MICAL3 PLCG1 DOCK1 ANK3 HACD3 ANXA6 RALGAPB ST3GAL3 ARHGAP35 ZNF248 SHANK2 PRKACB LSM14A EPB41 KDM4B DOP1A	1.01e-08	1489	237	32	28611215
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	HSP90B1 CAND1 DHX38 MDH2 PHKB NOMO2 HPRT1 PLCG1 PLCG2 VARS1 HSPA4L LDHA NOMO1 PDIA4 NOMO3	1.76e-08	344	237	15	30333137
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	DNAJB11 RPN1 DHX38 MDH2 EFTUD2 SLC25A3 PHKB AGO3 INTS11 SCO1 ANKRD28 STIP1 HACD3 LDHA PDIA4 LSM14A TUBAL3 PHLPP2 ATP5F1C	1.83e-08	573	237	19	28330616
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SYNRG ARHGAP32 MYO1D MCM5 GGA3 PHKB MVB12A SMG7 AGO3 ALMS1 BRCA2 NOMO2 ANKRD28 MICAL3 BRWD1 STXBP5 ANXA6 NOC3L DNAH7 HGS PRKACB EIF3G EPB41	2.60e-08	853	237	23	28718761
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SYNRG HSP90B1 CAND1 BCLAF1 DHX38 MDH2 NEK9 GGA3 EFTUD2 SLC25A3 SMG7 ALMS1 ANKRD28 STIP1 PLCG1 SMCHD1 NOC3L ARHGAP35 LDHA MASTL LSM14A EIF3G EPB41 AHNAK2	3.15e-08	934	237	24	33916271
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	HSP90B1 CAND1 MYO1D RPN1 GARS1 MRPL27 MCM5 MDH2 EFTUD2 SLC25A3 ANAPC10 HMCN2 TXNDC5 HPRT1 ANKRD28 STIP1 NUP160 SDHB ADRM1 HACD3 HSPA4L LDHA DICER1 PRKACA PRKACB LSM14A EIF3G TUBAL3 ATP5F1C	4.20e-08	1335	237	29	29229926
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	HSP90B1 CAND1 GARS1 MCM5 MDH2 EFTUD2 BPTF AGO3 ALMS1 STIP1 NUP160 VARS1 ADRM1 HSPA4L LDHA PDIA4 EIF3G	6.20e-08	494	237	17	26831064
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	DNAJB11 HSP90B1 CTU2 CAND1 ZMPSTE24 RPN1 GARS1 MDH2 NDUFB6 SLC25A3 BPTF FAT1 TXNDC5 NOMO2 HPRT1 ERP29 STIP1 NUP160 ADRM1 SMCHD1 APOB LDHA PDIA4 TMEM106B HGS PRKACA AURKB ATP5F1C	8.33e-08	1297	237	28	33545068
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	GABRB2 ENPP6 DDX19B CAND1 ZMPSTE24 MYO1D MDH2 NEB SH3BP4 SLC25A3 FAT1 GK SMPDL3B MVB12A PROM2 DPYS REXO5 NT5E ANXA6 LDHA VPS13D ASAH1 ANO6 HGS	1.49e-07	1016	237	24	19056867
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	DNAJB11 HSP90B1 CAND1 MYO1D BCLAF1 MCM5 MDH2 EFTUD2 SLC25A3 BPTF SMPDL3B TXNDC5 HPRT1 STIP1 NUP160 VARS1 HACD3 SMCHD1 ANXA6 LDHA DICER1 PDIA4 AURKB ATP5F1C	1.72e-07	1024	237	24	24711643
Pubmed	Human transcription factor protein interaction networks.	ARHGAP32 ZMPSTE24 MYO1D RPN1 PHF2 BPTF FAT1 SMG7 AGO3 ALMS1 NFIA ANKRD28 STIP1 GFPT2 ADRM1 HACD3 HSPA4L SMCHD1 NOC3L PDIA4 NOL4L NKX2-4 HGS LSM14A PABPC1L N4BP1 EIF3G HAL ATP5F1C	1.76e-07	1429	237	29	35140242
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	HSP90B1 ZMPSTE24 RPN1 MCM5 RO60 SH3BP4 SLC25A3 FAT1 TXNDC5 CANT1 NOMO2 SLC4A7 HACD3 ZDHHC5 LDHA NOMO1 PDIA4 ANO6 HGS FKBP7 EPB41 NOMO3 ATP5F1C	1.85e-07	952	237	23	38569033
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	A2M DNAJB11 HSP90B1 KIF1A DOCK11 MDH2 NDUFB6 PHKB GABARAPL1 AGO3 HSPA4L SMCHD1 LDHA OPHN1 WASH3P LSM14A	2.04e-07	475	237	16	31040226
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	EPHB2 HSP90B1 KIF1A SWT1 BCLAF1 DHX38 BPTF WWC2 DNAH8 TNS3 APOB DNAH7 SHANK2 LSM14A DOP1A	2.36e-07	420	237	15	28065597
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	EPHB2 A2M CAND1 BCLAF1 GARS1 MCM5 MDH2 EFTUD2 SLC25A3 TXNDC5 RBM19 STIP1 NUP160 VARS1 TNS3 ADRM1 ANXA6 NOC3L LDHA UFM1 PDIA4 ASAH1 ANO6 EIF3G HAL NEXN EPB41 AHNAK2	2.43e-07	1367	237	28	32687490
Pubmed	Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2.	DNAJB11 HSP90B1 RPN1 MDH2 SLC25A3 ERP29 HACD3 PDIA4	2.78e-07	94	237	8	36584595
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO1 NOMO3	3.12e-07	3	237	3	36011023
Pubmed	Spleen tyrosine kinase influences the early stages of multilineage differentiation of bone marrow stromal cell lines by regulating phospholipase C gamma activities.	SYK PLCG1 PLCG2	3.12e-07	3	237	3	28786489
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO1 NOMO3	3.12e-07	3	237	3	25576386
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GABRB1 GABRB2 SYNRG DNAJB11 ARHGAP32 HSP90B1 RPN1 BCLAF1 TXNDC5 ACSBG1 HPRT1 ANKRD28 STIP1 VARS1 SDHB SLC4A7 ANK3 ADRM1 HACD3 ARHGAP35 LDHA UFM1 SHANK2 SPHKAP EPB41	3.19e-07	1139	237	25	36417873
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	DNAJB11 HSP90B1 CAND1 GARS1 MCM5 MDH2 NEK9 EFTUD2 PHKB TXNDC5 HPRT1 EIF2B4 MICAL3 ERP29 STIP1 VARS1 ANK3 ADRM1 HSPA4L LDHA PREPL PABIR2 PDIA4 PRKACA EIF3G	3.74e-07	1149	237	25	35446349
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	A2M CAND1 MYO1D MDH2 NEDD4 SMPDL3B PTPRD TXNDC5 MVB12A CANT1 PROM2 CILP NT5E ANXA6 APOB LDHA HMCN1 ASAH1 ANO6 QPRT PRKACA PRKACB PABPC1L TNXB	3.79e-07	1070	237	24	23533145
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	DNAJB11 HSP90B1 RPN1 GARS1 PEX1 MCM5 RO60 MDH2 EFTUD2 SLC25A3 PHF2 CLCN3 TXNDC5 SMG7 HPRT1 VARS1 HSPA4L LDHA DNAH7 PDIA4 LSM14A PABPC1L EIF3G TUBAL3 ATP5F1C	3.99e-07	1153	237	25	29845934
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CAND1 BCLAF1 SH3BP4 EFTUD2 FAT1 RBM19 EIF2B4 ANKRD28 NUP160 SLC4A7 ANK3 NOC3L ZDHHC5 APOB LDHA PKHD1L1 DNAH7 ANO6 EPB41 ATP5F1C	4.56e-07	777	237	20	35844135
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ARHGAP32 HSP90B1 ZMPSTE24 RPN1 BCLAF1 SLC25A3 MICAL3 STIP1 DOCK1 ANK3 HACD3 HSPA4L ZDHHC5 PDIA4 MAP4K5 HGS EIF3G EPB41 ATP5F1C	4.80e-07	708	237	19	39231216
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HSP90B1 CAND1 RPN1 DHX38 GARS1 MCM5 MDH2 NEK9 EFTUD2 SLC25A3 TXNDC5 RBM19 HPRT1 EIF2B4 SCO1 STIP1 VARS1 SDHB SLC4A7 HACD3 HSPA4L SMCHD1 ARHGAP35 LDHA SBNO1 EIF3G AHNAK2 ATP5F1C	4.84e-07	1415	237	28	28515276
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	CTU2 CAND1 CMTR1 CMC1 RPN1 DHX38 MCM5 NEK9 C2CD5 SYK PLCG1 GFPT2 ADRM1 HACD3 LDHA PDIA4 SBNO1 EIF3G	6.61e-07	653	237	18	33742100
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	DNAJB11 HSP90B1 ERCC3 RPN1 BCLAF1 MCM5 EFTUD2 SLC25A3 GABARAPL1 GFPT2 VARS1 NOC3L APOB LDHA IFI16 PDIA4 HAL NEXN EPB41 TUBAL3 AURKB ATP5F1C	6.91e-07	949	237	22	36574265
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	HSP90B1 CAND1 ZMPSTE24 RPN1 GARS1 MDH2 EFTUD2 TXNDC5 NFIA HPRT1 ERP29 STIP1 ANK3 HACD3 LDHA PDIA4 PRKACA MASTL AHNAK2 ATP5F1C	8.20e-07	807	237	20	30575818
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	ACP5 GCNT1 MDH2 NEB NDUFB6 PRDM8 FAT1 SMPDL3B CLCN3 CLCN4 WDR89 PLCG2 DOCK1 ANK3 LIPF DNAH7 DICER1 UFM1 OPHN1 NOL4L QPRT ANKEF1 DEPDC5 TNXB ZNF286A AURKB	9.50e-07	1293	237	26	15342556
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	A2M DNAJB11 CAND1 RPN1 GARS1 MCM5 MDH2 ERP29 STIP1 PLCG1 NUP160 VARS1 HACD3 LDHA PDIA4 EIF3G ATP5F1C	1.10e-06	607	237	17	39147351
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO1 NOMO3	1.24e-06	4	237	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO1 NOMO3	1.24e-06	4	237	3	9267806
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	A2M DNAJB11 HSP90B1 RPN1 GARS1 MCM5 SLC25A3 NOMO2 SEL1L3 ANKRD28 VARS1 SMCHD1 LDHA NOMO1 ASAH1 NOMO3 ATP5F1C	1.26e-06	613	237	17	22268729
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	HSP90B1 CAND1 BCLAF1 SLC25A3 PHF2 STIP1 SMCHD1 LDHA HAL	1.36e-06	156	237	9	37108203
Pubmed	WDFY4 is required for cross-presentation in response to viral and tumor antigens.	MYO1D NOMO2 STIP1 NUP160 SDHB NOMO1 EIF3G NOMO3 AHNAK2	1.36e-06	156	237	9	30409884
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	HSP90B1 CAND1 MYO7A RPN1 BCLAF1 MCM5 MDH2 NEDD4 EFTUD2 SCO1 SDHB BRWD1 HACD3 HSPA4L ANXA6 LDHA PDIA4 EIF3G DOP1A ATP5F1C	1.72e-06	847	237	20	35235311
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ZMPSTE24 DHX38 PEX1 C2CD5 PHKB WWC2 AMMECR1L CANT1 ERP29 PLCG1 GFPT2 BRWD1 SLC4A7 ANK3 APOB GLB1L2 CDCP1 PDIA4 NOL4L TIMP3 MASTL KIF13A NEXN	1.72e-06	1084	237	23	11544199
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	A2M ARHGAP32 MYO7A RPN1 GARS1 SH3BP4 SLC25A3 TXNDC5 AGO3 RBM19 ADRM1 HACD3 FHOD3 APOB NEXN	1.88e-06	496	237	15	31343991
Pubmed	A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins.	DNAJB11 HSP90B1 ERP29 PDIA4	1.99e-06	14	237	4	12475965
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	HSP90B1 SLC25A3 NOMO2 NOMO1 NOMO3	2.07e-06	31	237	5	19136429
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DDX19B SYNRG ARHGAP32 DOCK11 NEK9 SH3BP4 NEDD4 WWC2 ALMS1 WNK3 TNS3 SLC4A7 RALGAPB DNAH7 PABIR2 VPS13D KIF13A EPB41 DOP1A AHNAK2	2.20e-06	861	237	20	36931259
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	ARHGAP32 CAND1 C2CD5 SH3BP4 SLC25A3 SLC4A7 ANK3 STXBP5 ZDHHC5 LZTS1 ANO6 MAP4K5 EPB41	2.24e-06	377	237	13	38117590
Pubmed	A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.	DNAJB11 HSP90B1 MYO1D KIF1A RPN1 BCLAF1 MCM5 MDH2 SLC25A3 BPTF HPRT1 STIP1 ADRM1 NOC3L LDHA UFM1 PDIA4 EIF3G ATP5F1C	2.24e-06	786	237	19	29128334
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	A2M ERCC3 CMTR1 CENPC BCLAF1 NEK9 PHF2 PHKB ALMS1 SCO1 MICAL3 HACD3 SMCHD1 EPB41 KDM4B AURKB ATP5F1C	2.49e-06	645	237	17	25281560
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	A2M HSP90B1 MYH8 MYO1A MYO1D RPN1 GARS1 MDH2 SLC25A3 EIF2B4 TNS3 ADRM1 HACD3 HSPA4L LDHA PDIA4 PABPC1L	2.59e-06	647	237	17	26618866
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	CAND1 MYO1D RPN1 GARS1 MCM5 RO60 SLC25A3 HPRT1 HACD3 LDHA LSM14A EIF3G ATP5F1C	2.66e-06	383	237	13	29331416
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	DDX19B DNAJB11 MYO1D RPN1 BCLAF1 DHX38 MCM5 RO60 NEK9 C2CD5 SH3BP4 EFTUD2 HPRT1 STIP1 NUP160 VARS1 SLC4A7 RASGRF2 HACD3 HSPA4L UFM1 PDIA4 PRKACA EIF3G EPB41	2.76e-06	1284	237	25	17353931
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ENPP6 DNAJB11 LZTR1 DCDC1 CMC1 PEX1 ABCA8 C2CD5 PHF2 BPTF FAT1 ANAPC10 HMCN2 SMG7 AGO3 ALMS1 INTS11 SCO1 ANKRD28 BRWD1 ZNF618 DICER1 AURKB	2.79e-06	1116	237	23	31753913
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	SYNRG MYO7A RPN1 BCLAF1 MCM5 NEB EFTUD2 SLC25A3 INTS11 WHRN SMCHD1 APOB ARHGAP35 TUBAL3 ATP5F1C	2.84e-06	513	237	15	25798074
Pubmed	Evolutionarily conserved regulators of tau identify targets for new therapies.	DNAJB11 HSP90B1 ZMPSTE24 RPN1 NOMO2 ERP29 STIP1 ADRM1 HACD3 HSPA4L NOMO1 PDIA4 TMEM106B HGS NOMO3	3.05e-06	516	237	15	36610398
Pubmed	Regulation of survivin protein stability by USP35 is evolutionarily conserved.	USP38 USP35 AURKB	3.09e-06	5	237	3	34438346
Pubmed	Mosaic complementation demonstrates a regulatory role for myosin VIIa in actin dynamics of stereocilia.	MYO7A HPRT1 WHRN	3.09e-06	5	237	3	18160714
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ARHGAP32 CAND1 DOCK11 BCLAF1 NEK9 NEDD4 EFTUD2 PTPRD AGO3 ANKRD28 STIP1 WNK3 ANK3 ZNF618 PREPL SHANK2 LZTS1 SPHKAP PRKACA PRKACB CDH10	3.25e-06	963	237	21	28671696
Pubmed	Proteomic analysis of the 20S proteasome (PSMA3)-interacting proteins reveals a functional link between the proteasome and mRNA metabolism.	HSP90B1 GARS1 MDH2 EFTUD2 STIP1 LDHA ASAH1	3.60e-06	93	237	7	22079093
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	DNAJB11 CAND1 MYO1D RPN1 BCLAF1 ANAPC10 ALMS1 ANKRD28 MICAL3 SDHB HSPA4L SMCHD1 ZDHHC5 LDHA NOMO1 DNAI7 NOMO3	4.12e-06	670	237	17	22990118
Pubmed	High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.	HSP90B1 CMTR1 MYO1D RPN1 GARS1 RO60 EFTUD2 SLC25A3 VARS1 LDHA IFI16 DICER1 PDIA4 EIF3G	4.84e-06	469	237	14	37314180
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	DDX19B HSP90B1 ERCC3 CAND1 MYO1D RPN1 BCLAF1 GARS1 MCM5 MDH2 SH3BP4 EFTUD2 SLC25A3 SMPDL3B TXNDC5 ANKRD28 STIP1 VARS1 SDHB TNS3 HSPA4L NT5E HGS ATP5F1C	5.36e-06	1247	237	24	27684187
Pubmed	Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis.	HSP90B1 CAND1 BCLAF1 EFTUD2 SLC25A3 SCO1 HACD3 HSPA4L LDHA ATP5F1C	5.68e-06	236	237	10	36339263
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	A2M HSP90B1 ERCC3 MYO1D RPN1 BCLAF1 DHX38 GARS1 MCM5 EFTUD2 SLC25A3 RBM19 EIF2B4 NUP160 ADRM1 HACD3 SMCHD1 NOC3L LDHA IFI16 LSM14A EIF3G AURKB ATP5F1C	6.12e-06	1257	237	24	36526897
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	DDX19B DNAJB11 HSP90B1 CAND1 RPN1 GARS1 MCM5 NEK9 EFTUD2 SLC25A3 ANAPC10 NOMO2 HPRT1 NUP160 VARS1 SDHB ADRM1 HACD3 HSPA4L LDHA NOMO1 NOMO3 AURKB ATP5F1C	6.12e-06	1257	237	24	37317656
Pubmed	Multiple molecular chaperones interact with apolipoprotein B during its maturation. The network of endoplasmic reticulum-resident chaperones (ERp72, GRP94, calreticulin, and BiP) interacts with apolipoprotein b regardless of its lipidation state.	HSP90B1 APOB PDIA4	6.16e-06	6	237	3	9694898
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	DDX19B HSP90B1 CAND1 MYO1A RPN1 DHX38 MCM5 EFTUD2 USP38 ANKRD28 STIP1 NUP160 VARS1 ADRM1 NOC3L PREPL DICER1 PABIR2 PRKACA EIF3G PHLPP2	6.25e-06	1005	237	21	19615732
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	DNAJB11 HSP90B1 CAND1 RPN1 BCLAF1 MCM5 MDH2 EFTUD2 SLC25A3 EIF2B4 ANKRD28 MICAL3 ERP29 STIP1 SDHB HACD3 HSPA4L ANXA6 NOC3L LDHA IFI16 DICER1 EIF3G NEXN AHNAK2 ATP5F1C	6.64e-06	1440	237	26	30833792
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	UBE4B PHF2 ACSBG1 RBM19 SMCHD1 DEPDC5 N4BP1	6.65e-06	102	237	7	9734811
Pubmed	The protein interaction landscape of the human CMGC kinase group.	A2M ERCC3 CAND1 BCLAF1 NEB C2CD5 EFTUD2 AMMECR1L GABARAPL1 ALMS1 STIP1 VARS1 NOC3L NOL4L SHANK2 ASAH1 PRKACA	6.66e-06	695	237	17	23602568
Pubmed	A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity.	DNAJB11 HSP90B1 RO60 MDH2 STIP1 HSPA4L ANXA6 LDHA	7.38e-06	145	237	8	23349634
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	DNAJB11 HSP90B1 CMTR1 RPN1 SPEG GARS1 MCM5 MDH2 NDUFB6 NEDD4 EFTUD2 SLC25A3 FAT1 TXNDC5 NOMO2 GFPT2 VARS1 SDHB SLC4A7 HACD3 LDHA NOMO1 PDIA4 HAL NOMO3 ATP5F1C	7.59e-06	1451	237	26	30550785
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SYNRG LZTR1 UBE4B MYO7A SPEG DGKQ MCM5 GGA3 SH3BP4 FAT1 CANT1 PROM2 RBM19 INTS11 MICAL3 PLCG1 ZDHHC5 RAPGEF1 ARHGAP35 SHANK2 DEPDC5 AHNAK2	7.97e-06	1105	237	22	35748872
Pubmed	USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.	DNAJB11 HSP90B1 CAND1 MYO1D RPN1 MCM5 RO60 EFTUD2 SLC25A3 SCO1 HACD3 HSPA4L TUBAL3 AURKB ATP5F1C	9.01e-06	565	237	15	33567341
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	HSP90B1 CAND1 RPN1 MCM5 EFTUD2 SLC25A3 NUP160 VARS1 ATP5F1C	9.18e-06	197	237	9	31620119
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	HSP90B1 CAND1 RPN1 MCM5 NEK9 EFTUD2 SLC25A3 TXNDC5 STIP1 NUP160 VARS1 HACD3 HSPA4L NOMO1 EIF3G ATP5F1C	9.19e-06	638	237	16	33239621
Pubmed	Myosins: a diverse superfamily.	MYO1A MYO1D MYO7A	1.07e-05	7	237	3	10722873
Pubmed	TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)346, a Regulatory Site of Syk.	SYK PLCG1 PLCG2	1.07e-05	7	237	3	27609517
Pubmed	Nascent lipidated apolipoprotein B is transported to the Golgi as an incompletely folded intermediate as probed by its association with network of endoplasmic reticulum molecular chaperones, GRP94, ERp72, BiP, calreticulin, and cyclophilin B.	HSP90B1 APOB PDIA4	1.07e-05	7	237	3	12397072
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 HSP90B1 GGA3 SMG7 ALMS1 ANK3 ZDHHC5 HGS N4BP1 AHNAK2	1.46e-05	263	237	10	34702444
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	SYNRG SLC25A3 ALMS1 ANKRD28 MICAL3 TNS3 ARHGAP35 DICER1 VPS13D	1.47e-05	209	237	9	36779422
Pubmed	HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease.	PLCG1 PLCG2 PRKACA PRKACB	1.68e-05	23	237	4	9730685
Pubmed	The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases.	PLCG1 PLCG2 PRKACA PRKACB	1.68e-05	23	237	4	9278385
Pubmed	Phospholipase Cγ2 (PLCγ2) is key component in Dectin-2 signaling pathway, mediating anti-fungal innate immune responses.	SYK PLCG1 PLCG2	1.71e-05	8	237	3	22041900
Pubmed	Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.	SYK PLCG1 PLCG2	1.71e-05	8	237	3	11390470
Pubmed	Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling.	SYK PLCG1 PLCG2	1.71e-05	8	237	3	8885868
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO2 NOMO1 NOMO3	1.71e-05	8	237	3	15257293
Pubmed	Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.	HSP90B1 CAND1 RPN1 GARS1 MDH2 EFTUD2 SLC25A3 LDHA EIF3G ATP5F1C	1.89e-05	271	237	10	26816005
Pubmed	Repression of rRNA transcription by PARIS contributes to Parkinson's disease.	HSP90B1 CAND1 MYO1D RPN1 EFTUD2 SLC25A3 NUP160 NOC3L LDHA ATP5F1C	1.95e-05	272	237	10	25315684
Pubmed	Delineating WWOX Protein Interactome by Tandem Affinity Purification-Mass Spectrometry: Identification of Top Interactors and Key Metabolic Pathways Involved.	CAND1 RPN1 GARS1 RO60 HPRT1 STIP1 SDHB HACD3 ATP5F1C	1.98e-05	217	237	9	30619736
Interaction	NTRK3 interactions	DNAJB11 ARHGAP32 HSP90B1 RPN1 GGA3 SH3BP4 SLC25A3 SCO1 PLCG1 PLCG2 SLC4A7 ANK3 HACD3 HSPA4L PDIA4 TMEM106B TIMP3 MAP4K5 HGS	8.53e-08	374	234	19	int:NTRK3
Interaction	MET interactions	DNAJB11 GGA3 SLC25A3 FAT1 TXNDC5 HPRT1 SYK PLCG1 PLCG2 TNS3 UFM1 PDIA4 TMEM106B HGS ATP5F1C	1.63e-06	290	234	15	int:MET
Interaction	HUWE1 interactions	DNAJB11 HSP90B1 CAND1 RPN1 GARS1 MCM5 MDH2 NEK9 EFTUD2 SLC25A3 BPTF BRCA2 NOMO2 HPRT1 ERP29 STIP1 NUP160 VARS1 SDHB TNS3 ADRM1 HACD3 HSPA4L CDCP1 LDHA IFI16 TMEM106B PRKACA KIF13A AHNAK2 AURKB ATP5F1C	1.92e-06	1110	234	32	int:HUWE1
Interaction	DNAJC10 interactions	DNAJB11 HSP90B1 CAND1 RPN1 EFTUD2 TXNDC5 ERP29 STIP1 HSPA4L IFI16 NOMO1 PDIA4 TMEM106B AURKB	2.28e-06	260	234	14	int:DNAJC10
Interaction	RIPK4 interactions	ENPP6 DNAJB11 HSP90B1 CAND1 UBE4B BCLAF1 MDH2 SLC25A3 TXNDC5 SMG7 SCO1 STIP1 ANK3 HSPA4L PREPL PDIA4 AURKB ATP5F1C	5.08e-06	446	234	18	int:RIPK4
Interaction	EPHA10 interactions	DNAJB11 HSP90B1 RPN1 TXNDC5 ERP29 HSPA4L PDIA4 NOMO3	7.14e-06	86	234	8	int:EPHA10
Interaction	BIRC3 interactions	HSP90B1 CAND1 MYO1D RPN1 BCLAF1 DHX38 GARS1 MCM5 RO60 MDH2 NEK9 EFTUD2 SLC25A3 PHF2 TXNDC5 RBM19 HPRT1 CC2D2A ERP29 STIP1 USP35 NUP160 VARS1 SDHB HACD3 HSPA4L SMCHD1 ANXA6 APOB LDHA NOMO1 PDIA4 PRKACA ATP5F1C	1.28e-05	1334	234	34	int:BIRC3
Interaction	UBE2M interactions	CYP1A1 HSP90B1 CAND1 RPN1 GARS1 MCM5 NEDD4 EFTUD2 SLC25A3 TXNDC5 HPRT1 STIP1 VARS1 ADRM1 HSPA4L LDHA PDIA4 QPRT EIF3G EPB41 TUBAL3	2.54e-05	651	234	21	int:UBE2M
Interaction	AKAP1 interactions	DNAJB11 HSP90B1 ZMPSTE24 RPN1 PEX1 SLC25A3 GK SMG7 SCO1 ERP29 STIP1 LDHA PDIA4 VPS13D PRKACA PRKACB TUBAL3 AURKB	2.57e-05	503	234	18	int:AKAP1
Interaction	ACADM interactions	HSP90B1 CAND1 RPN1 MDH2 SLC25A3 STIP1 GFPT2 LDHA AURKB ATP5F1C	2.93e-05	169	234	10	int:ACADM
Interaction	BRAF interactions	DNAJB11 HSP90B1 PHKB BRCA2 NOMO2 DOCK1 HSPA4L LIPF NOMO1 PRKACA NOMO3	3.96e-05	212	234	11	int:BRAF
Interaction	ARHGAP36 interactions	CAND1 RPN1 MCM5 PTPRD HACD3 PREPL PRKACA PRKACB	5.60e-05	114	234	8	int:ARHGAP36
Interaction	DNAJC3 interactions	DNAJB11 HSP90B1 RPN1 TXNDC5 NOMO2 ERP29 PLCG1 PCDHB3 GLB1L2 PDIA4 TMEM106B	7.06e-05	226	234	11	int:DNAJC3
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GABRB2 KIF1A MYO7A SPEG PEX1 NEB C2CD5 PRDM8 RUNDC3A CLCN4 MICAL3 WNK3 BRWD1 ANK3 STXBP5 FHOD3 ARHGAP35 PREPL DICER1 ZNF248 NOL4L SHANK2 PRKACB KIF13A EPB41 DOP1A AHNAK2	2.34e-06	1106	234	27	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EPHB2 CAND1 CENPC GCNT1 C2CD5 NEDD4 BPTF FAT1 ANAPC10 BRCA2 ANKRD28 MICAL3 NUP160 DOCK1 SLC4A7 SMCHD1 ARHGAP35 DICER1 MAP4K5 PRKACB N4BP1 PHLPP2	9.68e-06	856	234	22	M4500
Coexpression	GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP	CYP2C8 CMTR1 DHX38 GARS1 PTPRD PLCG2 SLC4A7 DNAH7 QPRT KDM4B	1.24e-05	198	234	10	M5170
Coexpression	GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN	CYP2C8 CMTR1 RPN1 MDH2 AMMECR1L GABARAPL1 AGO3 PCDHB3 PRKACA DOP1A	1.36e-05	200	234	10	M8225
Coexpression	GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP	RPN1 GCNT1 BRCA2 VARS1 HACD3 APOB LDHA PREPL NOMO1 PRKACA	1.36e-05	200	234	10	M4139
Coexpression	GSE7852_LN_VS_THYMUS_TREG_UP	BCLAF1 AGO3 NFIA NT5E CDCP1 QPRT ATG4C KIF13A RBM43 PHLPP2	1.36e-05	200	234	10	M5737
Coexpression	TIEN_INTESTINE_PROBIOTICS_2HR_DN	ERCC3 GABARAPL1 CLCN4 TNS3 NOC3L UFM1 N4BP1	1.53e-05	89	234	7	M8916
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE	HSP90B1 RPN1 NDUFB6 TXNDC5 NOMO2 PLCG2 NOMO1 PDIA4 NOMO3	1.60e-05	162	234	9	M41204
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL	SPEG ABCA8 SH3BP4 HMCN2 NOMO2 USP35 PLCG2 NOMO1 HMCN1 PLD5 HAS2 NOMO3 AHNAK2	2.04e-05	355	234	13	M45758
Coexpression	GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	CAND1 GCNT1 PHF2 WWC2 PLCG1 BRWD1 NOC3L OPHN1 SBNO1	3.84e-05	181	234	9	M6849
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	SYNRG DNAJB11 HSP90B1 UBE4B RPN1 PHKB TXNDC5 NOMO2 EIF2B4 SEL1L3 HACD3 ANXA6 RALGAPB NOMO1 PDIA4 PABPC1L	6.31e-05	573	234	16	M41006
Coexpression	RODRIGUES_THYROID_CARCINOMA_DN	MYO1D ANKRD28 ANK3 ARHGAP35 DICER1 SHANK2	7.13e-05	78	234	6	M9814
Coexpression	GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN	MYO1D SPEG RO60 MDH2 SYK LDHA SLC9A5 DEPDC5 EIF3G	7.69e-05	198	234	9	M3240
Coexpression	GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP	ACP5 MCM5 TLR7 NDUFB6 SH3BP4 SEL1L3 MICAL3 TNS3 NT5E	7.69e-05	198	234	9	M5541
Coexpression	GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	DNAJB11 CMC1 MDH2 CANT1 HPRT1 SMCHD1 LDHA HGS RRH	7.99e-05	199	234	9	M6194
Coexpression	GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN	CENPC NDUFB6 GGA3 NEDD4 GK RBM19 IFI16 PDIA4 VPS13D	8.30e-05	200	234	9	M8389
Coexpression	GSE27786_BCELL_VS_CD4_TCELL_UP	CMTR1 ACP5 GK PNPLA1 TXNDC5 TNS3 BRWD1 LSM14A AURKB	8.30e-05	200	234	9	M4799
Coexpression	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	A2M ERCC3 PHKB MVB12A NFIA HACD3 ARHGAP35 VPS13D CARD11	8.30e-05	200	234	9	M7978
Coexpression	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP	GABRB2 CYP2C18 ERP29 STIP1 PLCG1 PLCG2 ANK3 IFI16 EIF3G	8.30e-05	200	234	9	M5261
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP	DNAJB11 HSP90B1 ZMPSTE24 RPN1 MRPL27 RO60 TCAIM CLCN3 TXNDC5 USP38 CANT1 NOMO2 SEL1L3 STIP1 HACD3 NOC3L PDIA4	9.62e-05	658	234	17	M40871
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN	SYNRG MYO1D UBE4B BPTF SEL1L3 WDR89 PLCG1 BRWD1 SLC4A7 RASGRF2 HACD3 NT5E STXBP5 ANXA6 PREPL TRBV27 NOL4L SBNO1 PRKACB CARD11 ZNF286A PHLPP2	1.17e-04	1012	234	22	M40864
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 NOMO2 SEL1L3 PLCG2 NOMO1 PDIA4 NOMO3	9.10e-09	197	236	11	99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 A2M COL22A1 NEB FAT1 PTPRD PTPRQ APOB PKHD1L1 HMCN1	5.61e-08	184	236	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 A2M COL22A1 NEB FAT1 PTPRD PTPRQ APOB PKHD1L1 HMCN1	5.61e-08	184	236	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 A2M COL22A1 NEB FAT1 PTPRD PTPRQ APOB PKHD1L1 HMCN1	5.61e-08	184	236	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LAM-Lymphoid-B-cell-2\|Lymphoid / Condition, Lineage and Cell class	DNAJB11 HSP90B1 SMPDL3B TXNDC5 SEL1L3 ANKRD28 PKHD1L1 UFM1 PDIA4 QPRT	6.22e-08	186	236	10	bcfe0bf2f7f745146b74496a4fcfccd869ad7c6f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 DCDC1 DOCK11 EFCAB13 FAT1 CFAP54 SEL1L3 TNS3 DOCK1 DNAH7	7.97e-08	191	236	10	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 VARS1 PKHD1L1 NOMO1 PDIA4	8.37e-08	192	236	10	ec279980602292fc8ed6362edd36a5c772d59777
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 VARS1 PKHD1L1 NOMO1 PDIA4	8.79e-08	193	236	10	ce3873ece35fd2155ea235cb3c8bcd235cc0ebde
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 VARS1 PKHD1L1 NOMO1 PDIA4	8.79e-08	193	236	10	8f57b0473a2c2c07f83e5fe70f16862b1bb3b514
ToppCell	severe-Plasmablast\|World / disease stage, cell group and cell class	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 VARS1 PKHD1L1 NOMO1 PDIA4	9.23e-08	194	236	10	49e8f90db571a89b8a26aef31fcacd66429fed11
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast\|COVID-19_Severe / Disease, condition lineage and cell class	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 VARS1 PKHD1L1 NOMO1 PDIA4	1.17e-07	199	236	10	e6422b65e22e5aa8dfaebdae5be76dd78b978604
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T\|COVID-19_Mild / Disease, condition lineage and cell class	SYNRG ACP5 MCM5 PRDM8 SMG7 PLCG1 WNT3 TRBV27 QPRT N4BP1	1.17e-07	199	236	10	f307d4887b28cf60a591439e278fd668409cb104
ToppCell	normal-na-Lymphocytic_B-B_plasma-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	MYO1D SMPDL3B CLCN3 TXNDC5 BRCA2 PKHD1L1 NOMO1 ARHGEF39 ANKEF1	3.27e-07	170	236	9	c5b87974dfddf9780051f7f5693eeeb0c606a3fe
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYO1D TLR7 TXNDC5 SEL1L3 PLCG2 PKHD1L1 NOMO1 PDIA4 FKBP7	5.29e-07	180	236	9	8e96f8646c002768b272359af485dc0ab57e0ccd
ToppCell	mild-B_cell\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYO1D TXNDC5 SEL1L3 ZNF618 RAPGEF1 PKHD1L1 FKBP7 PABPC1L KDM4B	6.08e-07	183	236	9	175aaf8fbbff52eab87d78a49d5ab02cd489c438
ToppCell	ILEUM-inflamed-(5)_Plasma\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DNAJB11 HSP90B1 SMPDL3B SEL1L3 ANKRD28 PKHD1L1 UFM1 PDIA4 QPRT	6.96e-07	186	236	9	4d105437487bf04f8cd6129b822d5c060af0bee8
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	8.32e-07	190	236	9	84eb7761f537d270673909a71d4f122e826769d5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 PKHD1L1 NOMO1 PDIA4	8.32e-07	190	236	9	f85cdd79eefd699ada7a91bf4997cc730a9b9846
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 ANKRD28 PKHD1L1 PDIA4	8.69e-07	191	236	9	fca19f2719806f3dc2dd2add7252ab1198548f4d
ToppCell	PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 ANKRD28 PKHD1L1 PDIA4	8.69e-07	191	236	9	dd1d38a531a272a746c16807688013d29cab823a
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 ANKRD28 PKHD1L1 PDIA4	8.69e-07	191	236	9	208cd307826b5af89f8f10c0c915f90f80a25c6c
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|lung / Disease (COVID-19 only), tissue and cell type	DOCK11 ACP5 DCSTAMP GK SYK TNS3 RAPGEF1 CDCP1 ASAH1	8.69e-07	191	236	9	dab953682b8c9ed680a799161f837f792a7e4f33
ToppCell	COVID-19_Severe-Lymphoid_P\|COVID-19_Severe / Disease group, lineage and cell class	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	9.07e-07	192	236	9	3d0240491296757b3125f6e861bbaca06bbc5068
ToppCell	COVID-19_Severe-Lymphoid_P-Plasmablast\|COVID-19_Severe / Disease group, lineage and cell class	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	9.07e-07	192	236	9	90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	9.47e-07	193	236	9	227d82059a9f99937e0188ff57f2d0e485ebfe69
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	9.47e-07	193	236	9	38bb14df7f05c29565a1c7f175fafe636e543bf8
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	9.47e-07	193	236	9	3ba6d44248690b80f4caf791d463e60f1ab816c4
ToppCell	MS-plasma\|MS / Condition, Cell_class and T cell subcluster	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 PLCG2 PKHD1L1 UFM1 PDIA4	1.03e-06	195	236	9	de866c0eaec36d94a3101eb9f949ca9544207f33
ToppCell	MS-plasma-\|MS / Condition, Cell_class and T cell subcluster	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 PLCG2 PKHD1L1 UFM1 PDIA4	1.03e-06	195	236	9	b0a51dea06899e6a4477c3436c85e114cd8f6214
ToppCell	severe-Plasmablast\|severe / disease stage, cell group and cell class	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 PKHD1L1 NOMO1 PDIA4	1.03e-06	195	236	9	e11616ad568e50e4c720b50b0c071f484c31d16b
ToppCell	Mild/Remission-Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 ANKRD28 PKHD1L1 NOMO1 PDIA4	1.03e-06	195	236	9	52bdd609253613b7db75dccbc1c01c05e8d73f79
ToppCell	Mild/Remission-Plasmablast\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 ANKRD28 PKHD1L1 NOMO1 PDIA4	1.08e-06	196	236	9	dcf0a804a79a05454658498d1f87320c7e079219
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 DCDC1 EFCAB13 FAT1 TNS3 ANK3 FHOD3 DNAH7 SHANK2	1.12e-06	197	236	9	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M ABCA8 PTPRD GFPT2 HMCN1 TIMP3 HAS2 NEXN TNXB	1.12e-06	197	236	9	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	5'-Adult-LargeIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M ABCA8 NFIA GFPT2 CILP TIMP3 NEXN TNXB AHNAK2	1.27e-06	200	236	9	5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438
ToppCell	(20)_B_cell_IgA_Plasma\|World / shred on Cell_type and subtype	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 UFM1 PDIA4 QPRT	1.50e-06	204	236	9	fcca2135876031644a81d4aa3bc04145558f7745
ToppCell	COVID-19-lung-Mesothelial\|lung / Disease (COVID-19 only), tissue and cell type	GABRB1 GABRB2 SPEG PTPRQ GFPT2 DPYS PKHD1L1 DDX25	1.89e-06	156	236	8	e1f563869b3bf997eaa2e756e31b53db1a478903
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 COL22A1 PTPRQ PKHD1L1 RDH16 HMCN1 SPHKAP PLD5	2.29e-06	160	236	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 COL22A1 PTPRQ PKHD1L1 RDH16 HMCN1 SPHKAP PLD5	2.29e-06	160	236	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|390C / Donor, Lineage, Cell class and subclass (all cells)	MYO7A NEDD4 EIF2B4 ANKRD28 SLC4A7 GPR19 ST3GAL3 ARHGEF39	3.44e-06	169	236	8	cfc9ff103d13a2d5eacc457e800f53fdd29f7738
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DNAJB11 MYO1D SMPDL3B TXNDC5 NOMO2 SEL1L3 PKHD1L1 PDIA4	4.45e-06	175	236	8	3b5346fba617292de71963b6175e85a4f182fe30
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	BRCA2 ANK3 SMCHD1 IFI16 MASTL N4BP1 NEXN RBM43	5.26e-06	179	236	8	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	368C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HSP90B1 MYO1D RPN1 SMPDL3B TXNDC5 SEL1L3 PDIA4 QPRT	6.18e-06	183	236	8	7733cf919eda146efe41c93990658ce92db73aa8
ToppCell	ILEUM-inflamed-(5)_IgA_plasma_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DNAJB11 HSP90B1 SEL1L3 ANKRD28 PKHD1L1 UFM1 PDIA4 QPRT	6.18e-06	183	236	8	a113558ca4220bac31f9336033dff82a618d9258
ToppCell	368C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HSP90B1 MYO1D RPN1 SMPDL3B TXNDC5 SEL1L3 PDIA4 QPRT	6.18e-06	183	236	8	d91441cbf94f5c3b7c36f2ca3a46895870bd730f
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP6 RO60 RUNDC3A CLCA1 RASGRF2 SLC9A5 TIMP3 PABPC1L	6.70e-06	185	236	8	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	droplet-Kidney-nan-18m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCNT1 GK PTPRD GABARAPL1 ANK3 APOB RDH16 TIMP3	7.24e-06	187	236	8	236e9857729670e87eed30fad58f49e1f56e4a85
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	7.83e-06	189	236	8	73ee4cfb1057832f700be59b6917dedde3e89880
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	7.83e-06	189	236	8	c296660061b46e3abae1e7cf29df20274e5a8add
ToppCell	COVID-19_Mild-Lymphoid_P-Plasmablast\|COVID-19_Mild / Disease group, lineage and cell class	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	7.83e-06	189	236	8	254f058850b41a5974a380f3710db7c01a51fb6b
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	7.83e-06	189	236	8	f2daf4889ef98bbefe3e44832618ac102a75b4d9
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	7.83e-06	189	236	8	a1bda6ed5c52a5d33d229018cb5982cae6305533
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	7.83e-06	189	236	8	31594cc59eb1c5b01407dfd72b1487ecca8bf5ec
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC1 DOCK11 EFCAB13 FAT1 PTPRD SEL1L3 MICAL3 FHOD3	7.83e-06	189	236	8	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	COVID-19_Mild-Lymphoid_P\|COVID-19_Mild / Disease group, lineage and cell class	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	7.83e-06	189	236	8	0b3d3bd697e79decae7e21c513fab9da3b2a47c5
ToppCell	mild-Lymphocytic-Plasmablast\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	A2M DNAJB11 MYO1D RPN1 TXNDC5 SEL1L3 PKHD1L1 PDIA4	7.83e-06	189	236	8	db2097e6e165004d47ed504e115083a4e4f4b147
ToppCell	B_cells-Plasmablasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	DNAJB11 CFAP54 SMPDL3B SEL1L3 PLCG2 PKHD1L1 PDIA4 QPRT	7.83e-06	189	236	8	87cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	7.83e-06	189	236	8	9de17ade3cc3e9cd1394338bd048fb1ce64ac50f
ToppCell	Control-Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 NOMO2 NOMO1 PDIA4	8.46e-06	191	236	8	3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	GABRB2 A2M ABCA8 PTPRD GFPT2 HMCN1 TIMP3 HAS2	8.46e-06	191	236	8	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	GABRB2 A2M ABCA8 PTPRD GFPT2 HMCN1 TIMP3 HAS2	8.46e-06	191	236	8	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	remission-Plasmablast\|remission / disease stage, cell group and cell class	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 ANKRD28 PKHD1L1 PDIA4	8.78e-06	192	236	8	4bcf22061905177ad8625b87be2fbca9bff03ec6
ToppCell	COVID-19_Moderate-Plasmablast\|COVID-19_Moderate / disease group, cell group and cell class	DNAJB11 MYO1D RPN1 TXNDC5 SEL1L3 PKHD1L1 NOMO1 PDIA4	8.78e-06	192	236	8	25c6c7a244190f82c7feab874bdec12490b7de4d
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular\|TCGA-Stomach / Sample_Type by Project: Shred V9	SMG7 WDR89 VARS1 PABIR2 NOL4L ARHGEF39 ANKEF1	9.04e-06	138	236	7	93497c0a5d5e54006653b2dedc7a7041e1a613e6
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACP5 PRDM8 SEL1L3 MICAL3 PLCG2 DNAH8 NT5E PKHD1L1	9.12e-06	193	236	8	de0213f2105b814f38ffbfd004ea7603230eed68
ToppCell	Smart-seq2-thymus_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 UFM1 PDIA4	9.12e-06	193	236	8	bd82961502db42a0c862d3a29a2babe8032384c8
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	A2M PLCG1 PLCG2 BRWD1 SLC4A7 ANK3 SMCHD1 PABPC1L	9.12e-06	193	236	8	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP6 NEDD4 TXNDC5 NFIA GFPT2 TIMP3 FKBP7 TNXB	9.47e-06	194	236	8	48063c9fe3e12aeff0707acada1baa2f8621f093
ToppCell	facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP6 NEDD4 TXNDC5 NFIA GFPT2 TIMP3 FKBP7 TNXB	9.47e-06	194	236	8	4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3
ToppCell	PBMC-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 MICAL3 PKHD1L1 PDIA4	9.47e-06	194	236	8	bd2c53fb064edfec76abe56a9ffaced0bda32ab0
ToppCell	PBMC-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 MICAL3 PKHD1L1 PDIA4	9.47e-06	194	236	8	7dbedbdece4271e10134c9338c85cb3e04484c75
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DCDC1 MYO1D CFAP54 NFIA ANK3 DNAH7 SHANK2 DNAI7	9.83e-06	195	236	8	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DCDC1 MYO1D CFAP54 NFIA ANK3 DNAH7 SHANK2 DNAI7	9.83e-06	195	236	8	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACP5 MCMDC2 SEL1L3 DNAH8 SLC4A7 ANXA6 NOC3L CARD11	9.83e-06	195	236	8	a4d36654b968acb1aea252ac203683939461f1d1
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACP5 MCMDC2 SEL1L3 DNAH8 SLC4A7 ANXA6 NOC3L CARD11	9.83e-06	195	236	8	cd811abd949ef201aef1c8515da5575ab1b1cfea
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACP5 MCMDC2 SEL1L3 DNAH8 SLC4A7 ANXA6 NOC3L CARD11	1.02e-05	196	236	8	fd756b247b2d8a291e8e71bec6f1e463d6557536
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M ABCA8 PTPRD HMCN1 TIMP3 HAS2 NEXN TNXB	1.02e-05	196	236	8	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACP5 MCMDC2 SEL1L3 MICAL3 DNAH8 SLC4A7 NOC3L CARD11	1.02e-05	196	236	8	0175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCell	Severe-Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 ANKRD28 NOMO1 PDIA4	1.02e-05	196	236	8	ee991f1d9936c656f4fbc2e0cec9e0166a34bc5b
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M ABCA8 PTPRD HMCN1 TIMP3 HAS2 NEXN TNXB	1.02e-05	196	236	8	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer\|World / Primary Cells by Cluster	GABRB2 KIF1A CLCN4 NFIA ANK3 LDHA SPHKAP CDH7	1.06e-05	197	236	8	41e823b14697827f657b13adb3afa581bd91a9cb
ToppCell	Severe-Plasmablast\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 NOMO1 PDIA4	1.06e-05	197	236	8	1089aa7991812378668d0f3d57f8000e6245a713
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 NOMO1 PDIA4	1.06e-05	197	236	8	fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M SPEG FAT1 GFPT2 FHOD3 TIMP3 PLD5 NEXN	1.06e-05	197	236	8	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 NOMO1 PDIA4	1.06e-05	197	236	8	1e63879633f20646e44873ae6b662f6faf4806fd
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DNAJB11 HSP90B1 RPN1 CFAP54 TXNDC5 SEL1L3 PDIA4 AURKB	1.06e-05	197	236	8	b754fad4f3caae6de95df901fd96ea8697fe41b1
ToppCell	mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma\|mLN / shred on region, Cell_type, and subtype	RUNDC3A SMPDL3B TXNDC5 ACSBG1 ANKRD28 PDIA4 QPRT HAS2	1.06e-05	197	236	8	a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7
ToppCell	mLN-B_cell-B_cell_IgA_Plasma\|mLN / Region, Cell class and subclass	RUNDC3A SMPDL3B TXNDC5 ACSBG1 ANKRD28 PDIA4 QPRT HAS2	1.06e-05	197	236	8	20822fce311326765b71337ce501ba44ea14f58f
ToppCell	severe-Plasmablast\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 VARS1 PKHD1L1 PDIA4	1.10e-05	198	236	8	0b1620ad4352ee5d599a72931aaceab4ca407498
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B\|COVID-19_Severe / Disease, condition lineage and cell class	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 MICAL3 PKHD1L1 PDIA4	1.10e-05	198	236	8	1831a777dd996c25f637d551d754ec1b9c23feb2
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAJB11 HSP90B1 MYO1D TXNDC5 SEL1L3 NOMO1 PDIA4 AURKB	1.10e-05	198	236	8	2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24
ToppCell	COVID_vent-Lymphocytic-Plasma_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DNAJB11 HSP90B1 MYO1D RPN1 TXNDC5 SEL1L3 NOMO1 PDIA4	1.10e-05	198	236	8	e84c5f712e1dea548d0e2aba6625598f9671d3a0
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-D\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	HSP90B1 ABCA8 NFIA PLCG2 GFPT2 IFI16 PDIA4 TNXB	1.10e-05	198	236	8	fd14efd8e6c74a04bde985c08dc34217c0ef1bab
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 MYO1D PTPRD DOCK1 ANK3 OPHN1 SHANK2 KIF13A	1.10e-05	198	236	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 MYO1D NFIA DOCK1 ANK3 STXBP5 OPHN1 SHANK2	1.14e-05	199	236	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	368C-Fibroblasts\|368C / Donor, Lineage, Cell class and subclass (all cells)	A2M ABCA8 NFIA GFPT2 TIMP3 FKBP7 NEXN TNXB	1.14e-05	199	236	8	dbf64b83e2dc311b68f299c3f306ee098efd664c
ToppCell	Sigmoid-B_cell-B_cell_IgA_Plasma\|Sigmoid / Region, Cell class and subclass	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 UFM1 PDIA4	1.14e-05	199	236	8	634e0b614ab45e7520da67375b3498db5442b7ae
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	BCLAF1 BPTF GABARAPL1 SLC4A7 IFI16 TMEM106B NEXN AHNAK2	1.14e-05	199	236	8	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	Transverse-(2)_B_cell-(20)_B_cell_IgA_Plasma\|Transverse / shred on region, Cell_type, and subtype	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 UFM1 PDIA4	1.14e-05	199	236	8	8caaa08b046f766af298d03961ccac6e4569e2a6
ToppCell	Sigmoid-(2)_B_cell-(20)_B_cell_IgA_Plasma\|Sigmoid / shred on region, Cell_type, and subtype	DNAJB11 HSP90B1 RPN1 TXNDC5 SEL1L3 ANKRD28 UFM1 PDIA4	1.14e-05	199	236	8	f3c583f8521f63834d1afbf8b07940fee7712f9a
Drug	AC1L1IZ2	DDX19B HSP90B1 MYH8 MYO1A MYO1D KIF1A GARS1 MDH2 GK CLCN4 RBM19 STIP1 PRKACA PRKACB TUBAL3 AURKB ATP5F1C	1.89e-08	304	234	17	CID000004795
Drug	trans-1,2-diphenylethylene	SLC25A3 CLCA1 CLCN3 CLCN4 ALMS1 SYK SLC4A7 GYPA TUBAL3	3.46e-06	117	234	9	CID000011502
Drug	pyrophosphate	MYH8 ERCC3 MYO1A MYO1D RPN1 ACP5 GARS1 MDH2 ANAPC10 ACSBG1 HPRT1 PLCG1 PLCG2 VARS1 DPYS CILP NT5E QPRT PRKACA CARD11 HAL	4.43e-06	654	234	21	CID000001023
Drug	Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A	ARHGAP32 KIF1A SPEG RO60 DCSTAMP NEK9 BRCA2 ANK3 VPS13D GYPA LSM14A	5.38e-06	193	234	11	6749_DN
Drug	0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A	EPHB2 SYNRG ARHGAP32 MYO1D DHX38 ALMS1 RBM19 SYK WHRN IFI16 VPS13D	5.38e-06	193	234	11	7057_UP
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A	CYP1A1 NEB SMG7 BRCA2 RBM19 PLCG1 NUP160 SMCHD1 VPS13D MAP4K5 N4BP1	6.87e-06	198	234	11	4808_DN
Drug	Solanine alpha [20562-02-1]; Up 200; 4.6uM; MCF7; HT_HG-U133A	EPHB2 A2M DGKQ WHRN DPYS DNAH7 RDH16 TIMP3 PRKACA KDM4B PHLPP2	7.20e-06	199	234	11	4166_UP
Drug	Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A	WWC2 DTWD1 CLCN3 ALMS1 BRCA2 PLCG2 BRWD1 SLC4A7 SMCHD1 NOC3L	2.08e-05	183	234	10	2750_DN
Drug	Monobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A	CYP1A1 SPEG SMG7 PLCG1 TNS3 BRWD1 NT5E VPS13D TIMP3 LSM14A	2.39e-05	186	234	10	3391_DN
Drug	Ethacrynic acid [58-54-8]; Up 200; 13.2uM; HL60; HG-U133A	SYNRG UBE4B EFHC1 GABARAPL1 CLCN3 CANT1 PLCG1 HSPA4L IFI16 PREPL	2.51e-05	187	234	10	1565_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A	EPHB2 DGKQ CLCA1 PLCG1 ANK3 RAPGEF1 ARHGAP35 VPS13D LZTS1 GYPA	3.28e-05	193	234	10	2682_UP
Drug	bicarbonate	EPHB2 MDH2 SLC25A3 CLCA1 SDHB SLC4A7 NT5E SLC26A9 PDIA4 SLC9A5 SHANK2 MAP4K5 GYPA	3.45e-05	325	234	13	CID000000767
Drug	T4-G	CYP1A1 UGT2B4 UGT2B10 HAS2	3.73e-05	19	234	4	CID000152424
Drug	Clorgyline hydrochloride [17780-75-5]; Up 200; 13uM; HL60; HG-U133A	ARHGAP32 DHX38 CLCN3 BRCA2 CANT1 RBM19 SEL1L3 NT5E IFI16 KDM4B	3.74e-05	196	234	10	1604_UP
Drug	retinoic acid; Down 200; 1uM; MCF7; HG-U133A	EPHB2 GABRB2 RO60 DCSTAMP RUNDC3A CLCN4 REXO5 WNT3 LZTS1 AHNAK2	3.91e-05	197	234	10	224_DN
Drug	Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A	EPHB2 RO60 GABARAPL1 WHRN LIPF DNAH7 SLC1A7 RDH16 LZTS1 GYPA	3.91e-05	197	234	10	6055_UP
Drug	6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A	CLCA1 BRCA2 PLCG1 SLC1A7 VPS13D TIMP3 GYPA RRH KIF13A DOP1A	3.91e-05	197	234	10	6813_UP
Drug	Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A	CYP1A1 SYNRG GABARAPL1 CLCN3 ALMS1 NUP160 SLC4A7 ARHGAP35 ANKEF1 LSM14A	3.91e-05	197	234	10	1799_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	GABRB2 LZTR1 RBM19 PLCG2 NUP160 BRWD1 REXO5 ARHGAP35 VPS13D SHANK2	3.91e-05	197	234	10	5746_DN
Drug	2-Chloropyrazine [14508-49-7]; Up 200; 35uM; PC3; HT_HG-U133A	A2M RUNDC3A DPYS VPS13D TIMP3 PRKACA HAL CDH10 KDM4B PHLPP2	3.91e-05	197	234	10	5750_UP
Drug	Oxybenzone [131-57-7]; Up 200; 17.6uM; PC3; HT_HG-U133A	EPHB2 GABRB2 CYP1A1 KIF1A RBM19 CILP ARHGAP35 N4BP1 CDH10 KDM4B	4.08e-05	198	234	10	6309_UP
Drug	splitomicin; Down 200; 20uM; PC3; HG-U133A	EPHB2 MYO7A RUNDC3A CLCN3 CLCN4 PLCG2 DOCK1 APOB MAP4K5 PRKACA	4.08e-05	198	234	10	661_DN
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	GABRB2 NEB SLC9A5 TIMP3 GYPA RRH DEPDC5 N4BP1 CDH7 KDM4B	4.08e-05	198	234	10	4316_UP
Drug	Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; HL60; HT_HG-U133A	NEK9 MICAL3 SLC4A7 ANK3 HSPA4L SLC1A7 VPS13D TIMP3 PRKACA LSM14A	4.44e-05	200	234	10	2573_UP
Drug	N'-nitrosoanatabine	CYP1A1 CYP2C8 UGT2B4 UGT2B10	4.63e-05	20	234	4	CID000051291
Drug	picrotoxinine	GABRB1 GABRB2 GARS1 CLCA1 CLCN3 CLCN4	5.50e-05	65	234	6	CID000004816
Drug	Biliton	MYO7A ACP5 UGT2B4 DNAH8 ASAH1	6.09e-05	41	234	5	CID000002974
Drug	chloride	GABRB1 GABRB2 GARS1 MDH2 SLC25A3 EFHC1 CLCA1 CLCN3 CLCN4 RBM19 SCO1 ERP29 WNK3 DPYS SLC4A7 SLC26A9 LDHA IFI16 SLC1A7 SLC9A5 SHANK2 GYPA DDX25 PRKACA PRKACB	6.29e-05	1029	234	25	CID000000312
Drug	N'-nitrosoanabasine	CYP1A1 CYP2C8 UGT2B4 UGT2B10	6.88e-05	22	234	4	CID000014335
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	CYP2C18 UGT2B4 UGT2B10	3.74e-05	9	229	3	EFO_0600040
Disease	serum metabolite measurement	GABRB1 ENPP6 CYP1A1 CYP2C8 CYP2C18 RPN1 DHX38 SH3BP4 PHKB ALMS1 NFIA PLCG2 NT5E ZNF618 WNT3 APOB LDHA MAP4K5 HAL PHLPP2	5.33e-05	945	229	20	EFO_0005653
Disease	Dent disease (implicated_via_orthology)	CLCN3 CLCN4	1.79e-04	3	229	2	DOID:0050699 (implicated_via_orthology)
Disease	aspartate aminotransferase measurement	MYO7A SLC25A3 WWC2 HMCN2 PTPRD CLCN4 KIAA2012 NUP160 VARS1 WHRN SLC4A7 WNT3 NOC3L ARHGAP35 TMEM106B LZTS1 MAP4K5 FKBP7	2.67e-04	904	229	18	EFO_0004736
Disease	Bipolar Disorder	GABRB1 GABRB2 HSP90B1 NEDD4 BRCA2 PLCG1 DNAH8 WHRN ANK3 LDHA SHANK2 CDH7	3.83e-04	477	229	12	C0005586
Disease	coronary artery disease	CYP1A1 KIF1A DHX38 EFCAB13 NEK9 ABCA8 NEDD4 PHF2 PRDM8 NFIA PLCG1 PLCG2 NUP160 TNS3 SETD9 WNT3 APOB OPHN1 TMEM106B TNXB KDM4B	4.39e-04	1194	229	21	EFO_0001645
Disease	Usher Syndrome, Type II	MYO7A WHRN	5.91e-04	5	229	2	C1568249
Disease	Progeria	ZMPSTE24 ANK3	5.91e-04	5	229	2	C0033300
Disease	apolipoprotein B measurement	DDX19B DHX38 EFCAB13 ABCA8 BPTF PRDM8 BRCA2 EIF2B4 PLCG1 BRWD1 APOB MAP4K5 ATG4C EIF3G	7.31e-04	663	229	14	EFO_0004615
Disease	melanoma	ERCC3 MYO7A BRCA2 SYK UGT2B10 STIP1 EPB41 KDM4B	7.50e-04	248	229	8	C0025202
Disease	primary ciliary dyskinesia (is_implicated_in)	BRWD1 DNAH7	8.81e-04	6	229	2	DOID:9562 (is_implicated_in)
Disease	L lactate dehydrogenase measurement	NUP160 LDHA MAP4K5	1.05e-03	26	229	3	EFO_0004808
Disease	cognitive behavioural therapy	COL22A1 NEB PRDM8 GYPA	1.08e-03	58	229	4	EFO_0007820
Disease	Hereditary retinal dystrophy	MYO7A WHRN	1.23e-03	7	229	2	C0154860
Disease	vanillylmandelate (VMA) measurement	UGT2B4 UGT2B10	1.23e-03	7	229	2	EFO_0800119
Disease	osteopetrosis (implicated_via_orthology)	CLCN3 CLCN4	1.23e-03	7	229	2	DOID:13533 (implicated_via_orthology)
Disease	retinal detachment	COL22A1 CDH7	1.23e-03	7	229	2	EFO_0005773
Disease	Strabismus	PHKB PTPRD ZNF618	1.45e-03	29	229	3	HP_0000486
Disease	mitochondrial encephalomyopathy (implicated_via_orthology)	VARS1 SDHB	1.63e-03	8	229	2	DOID:890 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	DHX38 ABCA8 BPTF PLCG1 BRWD1 APOB MAP4K5	1.72e-03	220	229	7	EFO_0004529, EFO_0008317
Disease	triglyceride measurement, intermediate density lipoprotein measurement	BPTF BRCA2 BRWD1 APOB MAP4K5	1.77e-03	111	229	5	EFO_0004530, EFO_0008595
Disease	late-onset Alzheimers disease	ABCA8 PLCG2 ANK3 TMEM106B SHANK2 HMCN1 CDH7 ATP5F1C	2.11e-03	292	229	8	EFO_1001870
Disease	sensorineural hearing loss (is_implicated_in)	MYO1A MYO7A WHRN	2.12e-03	33	229	3	DOID:10003 (is_implicated_in)
Disease	chronic kidney disease	DCDC1 RPN1 GCNT1 SH3BP4 PRDM8 MAP4K5 HAS2	2.50e-03	235	229	7	EFO_0003884
Disease	mitochondrial metabolism disease (implicated_via_orthology)	SLC25A3 SCO1 VARS1	2.51e-03	35	229	3	DOID:700 (implicated_via_orthology)
Disease	level of Triacylglycerol (51:3) in blood serum	APOB MAP4K5	2.59e-03	10	229	2	OBA_2045163
Disease	urinary metabolite measurement	CYP2C8 ALMS1 UGT2B4 PKHD1L1 SLC1A7 HAL CDH7	3.15e-03	245	229	7	EFO_0005116
Disease	response to statin, myopathy	RASGRF2 CDCP1	3.15e-03	11	229	2	EFO_0004145, GO_0036273
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	APOB MAP4K5	3.15e-03	11	229	2	OBA_2045170
Disease	salicylate measurement	DTWD1 PLD5	3.15e-03	11	229	2	EFO_0021161
Disease	plasma N-desmethylclozapine measurement	CYP1A1 UGT2B10	3.15e-03	11	229	2	EFO_0600039
Disease	urate measurement, bone density	CYP2C8 UBE4B ABCA8 PTPRD GFPT2 DNAH8 ZNF618 PREPL LZTS1 MAP4K5 PRKACB TNXB	3.47e-03	619	229	12	EFO_0003923, EFO_0004531
Disease	HMG CoA reductase inhibitor use measurement	DHX38 PRDM8 BRCA2 UGT2B10 APOB MAP4K5	3.69e-03	189	229	6	EFO_0009932
Disease	nervous system disease (implicated_via_orthology)	KIF1A SKOR1	3.76e-03	12	229	2	DOID:863 (implicated_via_orthology)
Disease	Oligospermia	BRWD1 DICER1	3.76e-03	12	229	2	C0028960
Disease	alpha-hydroxybutyric acid measurement	SYT10 MAP4K5	3.76e-03	12	229	2	EFO_0010458
Disease	end stage renal disease (is_implicated_in)	CYP1A1 CYP2C8 SLC9A5	3.96e-03	41	229	3	DOID:783 (is_implicated_in)
Disease	autistic disorder (is_implicated_in)	GABRB1 GABRB2 SHANK2	4.24e-03	42	229	3	DOID:12849 (is_implicated_in)
Disease	osteitis deformans	DCSTAMP DPYS	4.42e-03	13	229	2	EFO_0004261
Disease	esophageal cancer (is_implicated_in)	CYP1A1 LZTS1	4.42e-03	13	229	2	DOID:5041 (is_implicated_in)
Disease	Paraganglioma	MDH2 SDHB	4.42e-03	13	229	2	C0030421
Disease	gallbladder cancer (is_implicated_in)	CYP1A1 APOB	4.42e-03	13	229	2	DOID:3121 (is_implicated_in)
Disease	Autistic Disorder	GABRB1 LZTR1 MYO1D KIF1A SHANK2 PLD5 CDH10	4.44e-03	261	229	7	C0004352
Disease	urate measurement	DDX19B CYP1A1 DCDC1 DHX38 COL22A1 PRDM8 USP38 EIF2B4 ANKRD28 STIP1 VARS1 SHANK2 ANO6 MAP4K5 KDM4B	4.48e-03	895	229	15	EFO_0004531
Disease	metabolite measurement	CYP2C8 SVOPL BPTF ALMS1 UGT2B4 UGT2B10 DPYS ANK3 LIPF ASAH1 MAP4K5	4.58e-03	560	229	11	EFO_0004725
Disease	ascending aortic diameter	DCDC1 PRDM8 NOC3L HMCN1 HAS2	4.82e-03	140	229	5	EFO_0021787
Disease	coffee consumption measurement, tea consumption measurement	CYP1A1 NUP160 MAP4K5	4.83e-03	44	229	3	EFO_0006781, EFO_0010091
Disease	Malignant neoplasm of kidney	CYP1A1 BRCA2 SDHB	5.15e-03	45	229	3	C0740457
Disease	esophagus squamous cell carcinoma (is_implicated_in)	CYP1A1 FAT1 BRCA2	5.15e-03	45	229	3	DOID:3748 (is_implicated_in)
Disease	potassium measurement	CYP1A1 PRDM8 SLC4A7	5.15e-03	45	229	3	EFO_0009283
Disease	cryptic phenotype measurement	PRDM8 SLC4A7 GYPA	5.82e-03	47	229	3	EFO_0021487
Disease	BMI-adjusted leptin measurement	ACTL9 MAP4K5	5.89e-03	15	229	2	EFO_0007793
Disease	chenodeoxycholate measurement	CYP2C8 HMCN1	5.89e-03	15	229	2	EFO_0010471
Disease	triacylglycerol 52:3 measurement	APOB MAP4K5	5.89e-03	15	229	2	EFO_0010415
Disease	infant head circumference	PLCG1 SBNO1	5.89e-03	15	229	2	EFO_0004577
Disease	third ventricle volume measurement	PTPRD ANK3	5.89e-03	15	229	2	EFO_0010335
Disease	mean corpuscular hemoglobin concentration	RPN1 GARS1 NEB ARL17A ANAPC10 ACSBG1 UGT2B10 CC2D2A KIAA2012 TNS3 HACD3 HSPA4L ZDHHC5 MAP4K5 GYPA LSM14A EPB41	5.94e-03	1105	229	17	EFO_0004528
Disease	total lipids in lipoprotein particles measurement	DHX38 APOB MAP4K5	6.17e-03	48	229	3	EFO_0022309
Disease	social interaction measurement	PHF2 NFIA ZDHHC5 CDH7	6.25e-03	94	229	4	EFO_0009592
Disease	obsolete aging	RPN1 PRDM8 ST3GAL3 IFI16 ZNF248 MAP4K5 KIF13A	6.34e-03	279	229	7	GO_0007568
Disease	phospholipids in medium LDL measurement	EFCAB13 APOB MAP4K5	6.54e-03	49	229	3	EFO_0022183
Disease	decreased susceptibility to hepatitis C infection	COL22A1 PTPRD	6.70e-03	16	229	2	EFO_0010101
Disease	coffee consumption, cups of coffee per day measurement	CYP1A1 MAP4K5	6.70e-03	16	229	2	EFO_0004330, EFO_0006782
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	SYK WNT3	6.70e-03	16	229	2	C0334634
Disease	triacylglycerol 50:5 measurement	MAP4K5 PLD5	6.70e-03	16	229	2	EFO_0010412
Disease	gliosarcoma	LZTR1 CYP2C18	6.70e-03	16	229	2	C0206726
Disease	apolipoprotein A 1 measurement	CMTR1 DHX38 DGKQ ABCA8 EIF2B4 UGT2B10 ANKRD28 APOB TMEM106B SLC9A5 SBNO1 MAP4K5 ATG4C AURKB	6.76e-03	848	229	14	EFO_0004614
Disease	tuberculosis	CYP2C8 NEDD4 CFAP54 PTPRD STXBP5 PLD5	6.99e-03	216	229	6	MONDO_0018076
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	PLCG1 APOB MAP4K5	7.30e-03	51	229	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO7A PTPRQ WHRN	7.30e-03	51	229	3	cv:CN043650
Disease	Glycogen storage disease	PHKB LDHA	7.55e-03	17	229	2	cv:C0017919
Disease	platelet crit	CTU2 C2CD5 SH3BP4 PHKB USP38 NFIA SYK NUP160 SLC4A7 NOC3L APOB NOL4L SBNO1 MAP4K5 GYPA	7.75e-03	952	229	15	EFO_0007985

Protein segments in the cluster

Peptide	Gene	Start	Entry
KSVLITEDRVPKGSY	ZNF286A	201	Q9HBT8
SYKRSSFFIKIRPGE	EPB41	441	P11171
GTVLPTRKLTVENYK	CFAP54	1531	Q96N23
PFGSISRIYLAKDKT	EIF3G	261	O75821
YLKEREEFRKTGIPT	CMC1	81	Q7Z7K0
FINEKGVKRTATYLP	AMMECR1L	221	Q6DCA0
VFTVTPDTKSKVYLR	CDCP1	546	Q9H5V8
KGALPLDTVTFYKVI	ERP29	36	P30040
SIVKPISRGAFGKVY	MASTL	36	Q96GX5
TIVYPLSFKVSREKA	GPR19	166	Q15760
IYSKRVVTKASLPVG	ALMS1	3336	Q8TCU4
YKRTLKLPDGRTVTL	ACTL9	276	Q8TC94
GASILVKDYILKRTP	ANKRD28	606	O15084
TTDTKFRNYLIPKGT	CYP2C8	371	P10632
LKVGVAYVSVRVTPK	DGKQ	406	P52824
GYIAVVLPKFEESKS	ABITRAM	141	Q9NX38
GYTKKVDITFIPRRI	ANKEF1	711	Q9NU02
TYEIIFKIIGPKRLA	DOP1A	86	Q5JWR5
TTILYKLKLGETVPA	ARL17A	31	Q8IVW1
TKTKILAPAYFILGG	ASAH1	271	Q13510
KTTRLGKYPVLEVIV	CLCN4	361	P51793
KTPVYAEVKRVGDTL	AGO3	526	Q9H9G7
EKSEARIGIPSTKYT	DICER1	901	Q9UPY3
RIGIPSTKYTKETPF	DICER1	906	Q9UPY3
RSGTALPSYRKFVTK	BPTF	1826	Q12830
SPLYSVKTFEELRLK	DDX25	91	Q9UHL0
FKTPTISLKETIGKY	ATG4C	171	Q96DT6
SIYKPGQTVKFRVVS	A2M	136	P01023
TYFLGILKAKGTLRP	ARHGEF39	46	Q8N4T4
LRLVFDEYLKTTGKP	ANXA6	211	P08133
EYREDFVLTVTGKKP	NFIA	86	Q12857
YIEVFREKNVPTTKG	RBM19	361	Q9Y4C8
PTRTKGVAYVIFKEK	RBM43	56	Q6ZSC3
EKITVTPSSKELLFY	NOMO3	761	P69849
TRDTSLKGFYIPKGR	CYP1A1	391	P04798
IIETKGIKTEGLYRT	OPHN1	396	O60890
VLGIFIKYKELRTPT	RRH	46	O14718
YKTISQEFLTPGKLE	NEXN	361	Q0ZGT2
SLPVGEVKIGKRSYS	NOBOX	186	O60393
FLRTPKIVSGKDYNV	LDHA	71	P00338
YRLSVFIVFSAKLPK	ANO6	476	Q4KMQ2
TGTVFLQLPYSKRKF	DEPDC5	1506	O75140
VRSFPGSKEYKVKAI	FAT1	306	Q14517
ASKVYTKDGTPIFTL	DCDC1	1451	M0R2J8
EKITVTPSSKELLFY	NOMO2	761	Q5JPE7
QIYEKIVSGKVRFPS	PRKACA	246	P17612
TVEALYKFVVPKPRS	SLC25A3	241	Q00325
ELPFTIASKRIKYLG	nan	756	O00370
PAFRPVSLKSYSVEK	MICAL3	1356	Q7RTP6
ILSPIEETYKKFSGA	NKX2-4	16	Q9H2Z4
EVPTLTYEERVGFKK	LZTR1	346	Q8N653
TKLRSYEREKTSFGP	LZTS1	361	Q9Y250
RSITVYIPGKKFGED	MCMDC2	431	Q4G0Z9
TKIPLKRYSSLVIFP	NEDD4	256	P46934
AKQLSFYKIRTIAPG	NEK9	591	Q8TD19
SFTLPYPVKIKVRFS	HACD3	311	Q9P035
LKFVEKCSPIGVYTS	MCM5	391	P33992
LKVPIYFSTGLTEKA	INTS11	261	Q5TA45
TKIFIRSPKTLFYLE	MYO1A	676	Q9UBC5
AGGIISRIKSYSFPK	SYK	286	P43405
FKDGALLPTSTKVVY	HMCN2	1566	Q8NDA2
TYFSTPLLLGKKGIE	MDH2	286	P40926
TKLIREVFPDTKVYA	SMPDL3B	116	Q92485
APYKGEVATLKSRVT	DPYS	491	Q14117
GSKYGIISLRTLKIP	DCAF4L1	96	Q3SXM0
FYKTVSPALISRFKE	CAND1	371	Q86VP6
GRFLLPETKIGSVKY	CANT1	381	Q8WVQ1
REIFVAIKTLKSGYT	EPHB2	646	P29323
RIKTFYALAPVATVK	LIPF	191	P07098
ILGFTPEEKVSIYKL	MYH8	341	P13535
LPVFSLQEKSYIKGT	LCTL	321	Q6UWM7
SEKPYGIVEKKSRIF	NDUFB6	91	O95139
KILVSASFYPSVERK	DCSTAMP	401	Q9H295
PIYKKPRRTDLTFIT	DNAH8	4451	Q96JB1
EKITVTPSSKELLFY	NOMO1	761	Q15155
RVLPEDSYKVTTGKL	PNPLA1	106	Q8N8W4
LKKYGIPFSRITQEA	KDM4B	251	O94953
PKTFSTRKGALILYS	KIAA2012	61	Q0VF49
PYIGSKISLISKAEI	LSM14A	6	Q8ND56
VVSPKYLGDRVSEKV	GGA3	96	Q9NZ52
KKVEFTTGAYPRLSL	GABRB1	221	P18505
KLITKKVVFSTGSYP	GABRB2	216	P47870
GTRKTTPGFRLVEKY	QPRT	136	Q15274
ATYPIKAVKSGFRSV	PLCG2	1151	P16885
RKEFSPYGVITSAKV	PABPC1L	311	Q4VXU2
LRSRVKYGVKTTPES	NOL4L	116	Q96MY1
KVVYAFSPKIGRKLS	ARHGAP32	886	A7KAX9
QVPTRKDYGSKVSLF	EIF2B4	166	Q9UI10
DVRLSGKTKTVPGYL	MVB12A	121	Q96EY5
SGLSERVVVKYKPVA	HMCN1	1831	Q96RW7
ASLLVKRTPRSVGYK	HPRT1	161	P00492
TDYILKITPSTEKGF	PTPRQ	1161	Q9UMZ3
EKLYSPKRIDFTPVS	PABIR2	101	Q7Z309
SSPFVERLLKKGYEV	HSP90B1	551	P14625
PTVEARYKSFSIKIL	ERVK-9	301	P63126
IKIYTPVEESSIGKF	ANAPC10	156	Q9UM13
GKLYSILKIQSPLFT	APOB	2756	P04114
LYAVTKGPRSIETFK	FKBP7	141	Q9Y680
IIKEKTVVYGITTGF	HAL	156	P42357
QIYEKIVSGKVRFPS	PRKACB	246	P22694
IDISGKTVFITRYLK	CC2D2A	1291	Q9P2K1
SRFVFEAPYTLSGKK	DOCK11	1861	Q5JSL3
VRVKGAALKYLPTIV	DOCK1	791	Q14185
PRAVGKKLGFYSVTV	SLC1A7	286	O00341
IGVRSKYKLSTEQIP	GFPT2	206	O94808
VVKKTGLAPFVYLSD	BRCA2	3081	P51587
KRKYLVPSDLTVGQF	GABARAPL1	46	Q9H0R8
YLGPFKDTTIVKISI	CDH10	361	Q9Y6N8
LKVYKTLDTPFFSTG	CENPC	856	Q03188
LKETGYVVERPSTTK	BCLAF1	461	Q9NYF8
SPLYSVKSFEELRLK	DDX19B	86	Q9UMR2
AVSFVPRVETKLYSK	DNAH7	436	Q8WXX0
YTLIGSKFRLVVKTA	FHOD3	196	Q2V2M9
GVIFTIYKESKRPFS	HAS2	491	Q92819
SYGIRRLIKKSPSDV	GYPA	111	P02724
VSYKPKERLVTFSLD	DNAI7	471	Q6TDU7
LLTTVAYKLGRDKPV	GK	306	P32189
KPFTTRLADYLVLAK	ACSBG1	421	Q96GR2
GKEIKTLPVYVSFVQ	ANK3	3086	Q12955
KTVIGKRLYDSVPID	COL22A1	401	Q8NFW1
LRTYGKAPFSKTKVI	BRWD1	2101	Q9NSI6
FYKILGVPRSASIKD	DNAJB11	26	Q9UBS4
SPEIRSLSPEYKKIF	EFCAB13	51	Q8IY85
SLSPEYKKIFETSII	EFCAB13	56	Q8IY85
FSKIRSGKIYVNDLP	EFCAB13	181	Q8IY85
IVKVLSTTKPFEYET	IFI16	206	Q16666
YLGRTKVVKPYSTVD	EFHC1	466	Q5JVL4
RSVISYKTEEKPIFS	ATP5F1C	191	P36542
FKNYLIPKGTTIITS	CYP2C18	376	P33260
GFLDYKTTKIAVPLI	GLB1L2	461	Q8IW92
ITEYLRKLSKTGVPD	ERCC3	136	P19447
YFSVEPKTGVIKTAL	CDH7	201	Q9ULB5
SSFIKRRKYIVEPLS	GCNT1	101	Q02742
KEIVSRGVKVDYLTP	ENPP6	51	Q6UWR7
DFPLTKVYVVEGSKR	ZMPSTE24	246	O75844
YVKEFSPKLVGLTGT	SCO1	216	O75880
VRKSDVKKFLTPGYS	SBNO1	1156	A3KN83
PSFTVTYGKLVKLLS	PEX1	326	O43933
NFISVKGPELLSKYI	PEX1	901	O43933
ELYKLVTGKEPTRRF	CARD11	101	Q9BXL7
SFIPGAKITKYLGII	C2CD5	881	Q86YS7
VSTVYRTSEKLVKGP	CTU2	361	Q2VPK5
KGKPDTFLSTIEAIY	DTWD1	241	Q8N5C7
EIDIFSYKPTLLTSK	CMTR1	566	Q8N1G2
YVNGKKVTEPSILRS	KIF1A	566	Q12756
RTKRSGSVYEPLKSI	PHKB	21	Q93100
TATIAKRKSFIGTPY	MAP4K5	166	Q9Y4K4
ITITDLGTPRLKTKY	PCDHB3	421	Q9Y5E6
LTGLKPDTTYDVKVR	PTPRD	981	P23468
FKDITPSYKIRPLTE	NOC3L	266	Q8WTT2
LKIPSSVGRYKTFST	OR10K1	226	Q8NGX5
KGKSKFVPYRDSVLT	KIF13A	296	Q9H1H9
RFSVKTLLEKYTAEP	RUNDC3A	36	Q59EK9
TGRTLLSVPGYKEKV	VARS1	496	P26640
LFPRSIDVKYIGVKS	TMEM106B	116	Q9NUM4
ARKGSYVSAFRPVVK	SKOR1	586	P84550
IAASELGIPTIYFKK	SPHKAP	1631	Q2M3C7
GFKSLKPTQLTFYVR	TCAIM	76	Q8N3R3
VVSSEFRSSIPVYKK	SEL1L3	116	Q68CR1
GSTGPVLVFEKILYK	SLC4A7	666	Q9Y6M7
AGQLVKTIKTLPLFY	SMCHD1	611	A6NHR9
KTIKTLPLFYGSIVR	SMCHD1	616	A6NHR9
VLKGEKTFYLIRPAS	PHF2	261	O75151
IQLEPTFIKGYTRKA	STIP1	421	P31948
IFALYSSLKFKSRVP	PLD5	266	Q8N7P1
VGKIILSPFATTTKY	SH3BP4	631	Q9P0V3
TPGKLTKEELYTVLA	SYNRG	346	Q9UMZ2
LSSTYGKIGVKVFLV	SLC26A9	686	Q7LBE3
PGYFKTAVTSKERFL	RDH16	206	O75452
AVVLGKLSDIYKRPF	RASGRF2	676	O14827
KLSDIYKRPFTSIPV	RASGRF2	681	O14827
AFIALKSTDKRTVPY	PRDM8	56	Q9NQV8
PKEVRRDYSKGITVT	SMG7	566	Q92540
YLTKVGISPDKLRFR	GARS1	416	P41250
LDTFGRPVIVAYKKN	RPN1	401	P04843
ASSKILKYSFPVGLR	TMEM69	11	Q5SWH9
FIITLVVKSSFPEKG	TMEM69	226	Q5SWH9
KPEEILYKTLGFSVA	SETD9	111	Q8NE22
EKDVGSKTTLRITYP	ST3GAL3	196	Q11203
RTKVPAKDYFVATTI	SLC9A5	421	Q14940
RFDVSGYPTLKIFRK	PDIA4	246	P13667
SKKLVLSVYSAGRIP	WHRN	211	Q9P202
KTKLEFSVYPAPRIS	TUBAL3	171	A6NHL2
LKFVRILKTTEVPGF	SWT1	401	Q5T5J6
YGKVELVFSATPEKI	TNS3	291	Q68CZ2
FKTVEPTGKRFLLAV	RO60	361	P10155
LKVEFKTTRSGEPFI	STXBP5	296	Q5T5C0
KKGYLSFLIPSSLVD	NUP160	561	Q12769
GRKVSIVSKPVLYRT	ARHGAP35	1146	Q9NRY4
QGLIIKTEFLPTKYR	SVOPL	156	Q8N434
PTVEARYKSFSIKIL	ERVK-9	301	P63128
KLYSAVPGRLFVAVK	SHANK2	521	Q9UPX8
KSEGKLIYTLPLERT	ABCA8	741	O94911
KVIYPAVEGRIKFST	NT5E	536	P21589
IQTPSYGFSLLKVKI	AHNAK2	5511	Q8IVF2
TTVTPDKRKGLVYIQ	ADRM1	36	Q16186
YIGKVKASVTFLDPR	CILP	616	O75339
SAFTVIRKKYPTDGS	CLCA1	391	A8K7I4
TKFGKYPVLEVIIVA	CLCN3	421	P51790
TYRRIVKVDLKFPAS	AURKB	281	Q96GD4
LPTYVRLEKLFTAKA	ZNF618	761	Q5T7W0
REKIAYFTRAKISIP	WWC2	1171	Q6AWC2
EVATEVPKRKTGYFA	PHLPP2	1256	Q6ZVD8
TFVAKIVPYAAEGKR	SPEG	2991	Q15772
TTYRTFISPEELIKK	RAPGEF1	721	Q13905
IIFAVKTSKYFRPIR	PROM2	796	Q8N271
TLKFEVYPVSLTKTE	UGT2B4	71	P06133
GTVYEKFITPEDLSK	HSPA4L	636	O95757
YLTSFSGITKKILNP	REXO5	271	Q96IC2
KVVEKYFSGPAITLE	UBE4B	606	O95155
EKVFSKLLYPIVRGA	USP35	311	Q9P2H5
IKVFSSAKYPAPERL	WASH2P	86	Q6VEQ5
VITSLDPGRKYKFVL	TNXB	1116	P22105
KYSTIPKFGIEKEVR	HGS	196	O14964
VETLRAKYSLFKPPT	WNT3	256	P56703
IKVFSSAKYPAPERL	WASH3P	86	C4AMC7
ATFPVKGLKTGYRAV	PLCG1	1176	P19174
YIEASGKSLFKTRLP	ACP5	306	P13686
ERVPLKGIVSYTEKL	PREPL	646	Q4J6C6
EKRSPLGSVRSTKIY	DHX38	1191	Q92620
LTPLRTGKNYKIEFI	PKHD1L1	4156	Q86WI1
NPRYLITVTGKKLTV	TRBV27	26	A0A0K0K1C4
TILPDRELSKFKSYV	RALGAPB	591	Q86X10
ETTTSIGRIKPELYK	SYT10	201	Q6XYQ8
LQIKPRSFSGLTYLK	TLR7	116	Q9NYK1
KITSRFPKDTAYVLL	USP38	931	Q8NB14
TPRYLVIGTGKKITL	TRB	26	P0DTU4
FKITLTSDPRLPYKV	UFM1	6	P61960
FRAPLYKTVEIKGIQ	ZDHHC5	86	Q9C0B5
LKLEVYPTSLTKTEF	UGT2B10	71	P36537
YPTLLLFRGGKKVSE	TXNDC5	396	Q8NBS9
TPRYLVIGTGKKITL	TRBV25-1	26	A0A075B6N4
TGRKPLKYTESRKSF	ZNF530	206	Q6P9A1
KEPTYLLGIDTSKTV	WDR89	21	Q96FK6
VTVVLPDTKGKSYLF	EFTUD2	186	Q15029
LITRLPKGAVLYKTF	MRPL27	116	Q9P0M9
TAAATAPRIKKFAIY	SDHB	31	P21912
SVGYCITKPEVIFKI	ZNF248	46	Q8NDW4
LVKEGPFGTLVYTIK	TIMP3	51	P35625
QIYRKVTSGIKPASF	WNK3	356	Q9BYP7
LKGTTVLTYKPRFVD	VPS13D	2491	Q5THJ4
LFPTTLIRSYKFQKG	LEG1	251	Q6P5S2
ISVFKLPIYTSGSLK	LRRIQ3	351	A6PVS8
DVAYGKTKIFIRTPR	MYO1D	671	O94832
TGVQRFRDTLKIPYK	N4BP1	591	O75113
YGVSLIDPKTKDILT	MYO7A	2136	Q13402
KYRTKIETLNFTPVD	NEB	4146	P20929